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ABSTRACT  
The use of bias indicators in psychological measurement has been 
contentious, with some researchers questioning whether they actually 
suppress or moderate the ability of substantive psychological indictors to 
discriminate (McGrath, Mitchell, Kim, & Hough, 2010). Bias indicators on 
the MMPI-2-RF (F-r, Fs, FBS-r, K-r, and L-r) were tested for suppression or 
moderation of the ability of the RC1 and NUC scales to discriminate between 
Epileptic Seizures (ES) and Non-epileptic Seizures (NES, a conversion 
disorder that is often misdiagnosed as ES). RC1 and NUC had previously 
been found to be the best scales on the MMPI-2-RF to differentiate between 
ES and NES, with optimal cut scores occurring at a cut score of 65 for RC1 
(classification rate of 68%) and 85 for NUC (classification rate of 64%; Locke 
et al., 2010).  
The MMPI-2-RF was completed by 429 inpatients on the Epilepsy 
Monitoring Unit (EMU) at the Scottsdale Mayo Clinic Hospital, all of whom 
had confirmed diagnoses of ES or NES. Moderated logistic regression was 
used to test for moderation and logistic regression was used to test for 
suppression. Classification rates of RC1 and NUC were calculated at 
different bias level indicators to evaluate clinical utility for diagnosticians. 
No moderation was found. Suppression was found for F-r, Fs, K-r, and 
L-r with RC1, and for all variables with NUC. For F-r and Fs, the optimal 
RC1 and NUC cut scores increased at higher levels of bias, but tended to 
decrease at higher levels of K-r, L-r, and FBS-r. K-r provided the greatest 
ii 
suppression for RC1, as well as the greatest increases in classification rates 
at optimal cut scores, given different levels of bias. 
It was concluded that, consistent with expectations, taking account of 
bias indicator suppression on the MMPI-2-RF can improve discrimination of 
ES and NES. At higher levels of negative impression management, higher cut 
scores on substantive scales are needed to attain optimal discrimination, 
whereas at higher levels of positive impression management and FBS-r, 
lower cut scores are needed. Using these new cut scores resulted in modest 
improvements in accuracy in discrimination. These findings are consistent 
with prior research in showing the efficacy of bias indicators, and extend the 
findings to a psycho-medical context.    
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Introduction 
Validity scales, used to measure response bias, are commonly used in 
personality and clinical assessment to gauge how much credibility should be 
placed in substantive scales. These scales indicate whether a test-taker is 
approaching the test in a manner which is likely to over-represent somatic or 
psychiatric dysfunction, under-represent these characteristics, or result in 
randomness which would render the entire test noncredible; however, this is 
generally the only utility afforded these very interesting and informative 
scales. But rather than simply providing information as to whether the 
clinical variables can be usefully interpreted, validity scales may also hold 
information as to how the substantive variables should be interpreted. The 
same score on a depression scale, for example, may hold different diagnostic 
utility for a person who indicates through his or her response style that he or 
she is reporting a non-credible level of psychopathology versus a person who 
seems to be accurately reporting his or her level of functioning. Whereas 
there is literature suggesting that response bias affects the discriminant 
utility of clinical scale scores in cases such as psychiatric malingering and 
work force testing, there is a dearth of such literature in the medical field. At 
this point, the author is unaware of any studies examining the ways in which 
validity scales affect medical diagnostic utility of clinical scales. 
 The present study focused on this gap in the literature by exploring 
methods of using validity scores to improve the diagnostic utility of clinical 
scores on personality-related tests in a medical setting. Specifically, the 
present study tested the ability of bias indicators to either suppress or 
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moderate the predictive utility of clinical scale scores in medical and 
psychological diagnoses. In the case of suppression or moderation, predictive 
success of clinical scale scores at different levels of response bias was 
calculated to improve diagnostic utility. This method has not been utilized to 
date in the psycho-medical field. 
 The present study builds on Locke et al.'s 2010 study of discrimination 
of epileptic seizures (ES) and non-epileptic seizures (NES), a conversion 
disorder that mimics seizure activity without an underlying neurological 
disorder. Differentiating between ES and NES is a useful way to begin to 
address the problem of improved diagnosis through psychological assessment, 
as there are consistent differences in both validity and clinical scale scores 
between these populations, as well as reliable methods of medically 
diagnosing these cases. If the methods used in the present study succeed in 
improving diagnostic abilities of personality tests, it will provide a valuable 
technique that may have implications for diagnosis beyond ES and NES. It is 
also hoped that, in the process of developing new criteria for the 
discrimination of ES and NES by utilizing validity scales, this study will 
increase understanding of psychological processes involving NES. Because 
the Minnesota Multiphasic Personality Inventory-Restructured Form; 
(MMPI-2-RF; Ben-Porath & Tellegen, 2008) is in the process of becoming one 
of the most widely used personality tests, and as it has a range of well-
studied validity scales, it was the assessment tool used in this study.  
 The present review will first define and describe NES and the common 
characteristics of those that suffer from this unique disorder. It will then 
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discuss methods of differentiating NES from ES, first through physiological 
differences in NES and ES, then by psychological assessment strategies. 
Response biases and the ways in which they affect psychological assessments 
will be explored, as well as methods of correcting for response biases. Finally, 
the assessment indicators of greatest potential interest in this population will 
be described.  
Non-epileptic Seizures 
 NES are a specific form of conversion disorder, defined as the presence 
of "pseudoneurological" motor or sensory deficits, suggestive of a medical or 
neurological condition, and in the absence of any known underlying medical 
condition (American Psychiatric Association Task Force on DSM-IV, 2000). 
NES is the third of the four subtypes of conversion disorder listed, which are 
(a) With Motor Symptom or Deficit (such as paralysis, localized weakness, or 
inability to retain urine), (b) With Sensory Symptom or Deficit (such as 
anesthesia, blindness, deafness, or hallucinations), (c) with Seizures or 
Convulsions (NES), and (d) With Mixed Presentation. In all subtypes of 
conversion disorder, these deficits generally do not follow known anatomical 
or physiological pathways, the person rarely shows expected objective signs of 
physiological dysfunction, and presentation is reliant upon the patient's 
conceptualization of what such deficits may look like.  
 Of all conversion disorders, NES is unique in that, unlike other 
conversion symptoms such as pain or weakness, it is it is possible to 
objectively measure whether the symptoms are being caused by expected 
neurological activity in the moment. Epileptiform activity can be measured in 
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the brain during observed seizure activity through the use of 24-hour video 
monitoring with accompanying electroencephalogram, or video-EEG (VEEG), 
the "gold standard" of epilepsy diagnosis (Benbadis, 2005a; M. Reuber & 
Elger, 2003). With rare exception, the presence of such activity during 
seizure-like motor activity indicates ES, whereas the absence indicates a 
psychogenic cause. Although it is possible to have both ES and NES, it is 
generally rare, occurring in 5-10% of patients being referred to epilepsy 
monitoring units (EMUs) for differentiation of ES and NES (Lesser, Lueders, 
& Dinner, 1983; Locke et al., 2010; Martin et al., 2003), though in some 
studies, up to 20%-50% of people had mixed ES/NES (Gates, 2002; Mari et 
al., 2006; Sigurdardottir & Olafsson, 1998) 
 NES have gone by many names in their time, including factitious 
seizures (Schachter, Brown, & James Rowan, 1996). NES, and indeed all 
conversion disorders, should be differentiated from malingering or factitious 
disorders: the patient is not consciously faking symptoms for secondary gain, 
either external/financial, or emotional. But it can be difficult to distinguish 
between malingering/factitious disorder and conversion, especially when 
conversion symptoms are unbelievable and implausible (Babin & Gross, 
2002). Only intent differentiates a conversion disorder from malingering or 
factitious disorders, and this can be hard to accurately gauge. 
 Other names for NES include such terms as psychogenic seizures, 
psychogenic non-epileptic seizures (PNES), pseudoseizures, pseudoepileptic 
seizures, and hysterical seizures (Babin & Gross, 2002). Many of these have, 
for the most part, been rejected as inaccurate or derogatory (Gates, 2002); 
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however, it has been argued that the term "non-epileptic seizure" is, itself, 
incomplete. There are seizures that are non-epileptic but physiologic in 
nature, including those caused by syncope, transient ischemic attacks, acute 
neurological insults, nontoxic acute hallucinosis, and endocrine disturbances 
(Gates, 2002). All these can be accurately described as NES. Nonetheless, 
NES is the most common and preferred nomenclature for NES that are 
psychogenic in nature.  
 Conversion disorder is not uncommon, especially in a medical context. 
Whereas the prevalence of conversion disorders in the general population is 
estimated to be 11 - 500 per 100,000 people, it is estimated to be 1-14% of the 
general medical/surgical inpatient population (American Psychiatric 
Association Task Force on DSM-IV, 2000). Additionally, among almost 4500 
neurological inpatients with "typical neurological symptoms", a full 9% were 
found to have primary causes that were psychogenic in nature rather than 
neurological (Lempert, Dieterich, Huppert, & Brandt, 1990). For the NES 
subtype, the prevalence in the general population is estimated at 2-33 per 
100,000 people, and between 15-30% of people admitted to EMUs for ES/NES 
differentiation (Benbadis & Allen Hauser, 2000; Benbadis, 2005b).  
 Historically, "conversion" implied a literal conversion of anxiety 
symptoms into a physical symptom or "hysteric phenomenon", such as 
vomiting in place of moral disgust or anguish (Freud & Breuer, 1895). It is 
beyond the scope of this review to report on the possible and theoretical 
psychological underpinnings of conversion disorders, including NES. 
Nonetheless, although Freud's conversion theories are not applied as literally 
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today, by current DSM-IV-TR definition a conversion disorder must be 
preceded by some sort of psychological stressor or conflict. The person may 
not be aware of the role that such a stressor or conflict has created in his or 
her life (Babin & Gross, 2002). It has been noted that people with conversion 
disorders are far more likely to have been sexually or physically abused or 
neglected as children than comparison groups of the general population 
(Betts & Boden, 1992; Sar, Akyuz, Kundakci, Kiziltan, & Dogan, 2004) and 
patients with affective disorders (Roelofs, Keijsers, Hoogduin, Naring, & 
Moene, 2002). Patients with NES are no exception, and physical and sexual 
abuse is relatively common in this population (Betts & Boden, 1992). One 
study found that 59% of such persons had been sexually assaulted or raped 
as a child or adolescent, and 48% had been physically abused (Bowman & 
Markand, 1996). This same study found that overall, 88% of subjects had 
experienced significant trauma over the course of their lives, with 77% 
suffering sexual abuse or rape and 70% experiencing physical abuse. Trauma 
as a risk factor as been found in multiple studies (Arnold & Privitera, 1996; 
Rosenberg, Rosenberg, Williamson, Wolford, & George, 2000) and is 
associated more strongly with NES than ES (Alper, Devinsky, Perrine, 
Vazquez, & Luciano, 1993). 
 NES is a disorder primarily found in females, who account for roughly 
75% of diagnoses (Gates, 2002). Younger females tend to be more at risk than 
older females, with one study finding that the incidence of NES begins to 
decreases after age 24 (Sigurdardottir & Olafsson, 1998). Additionally, people 
with NES often have concurrent psychological issues and diagnoses. Common 
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concurrent diagnoses include affective disorders, PTSD, anxiety disorders, 
other somatoform disorders, personality disorders such as borderline and 
mixed personality disorder, and dissociative disorders (Bowman & Markand, 
1996; Drake, Pakalnis, & Phillips, 1992; Ettinger, Devinsky, Weisbrot, 
Ramakrishna, & Goyal, 1999; Sar et al., 2004 [Sar's study included people 
with conversion disorders, 77% of whom were NES]).  
 Personality testing has also shown general differences between the 
NES population and the general population, as well as medical controls. A 
2004 study found a higher degree of psychopathology in the NES population 
compared to patients with epilepsy and general population control subjects 
(Reuber, Pukrop, Bauer, Derfuss, & Elger, 2004). In this study, cluster 
analysis on the Dimensional Assessment of Personality Pathology - Basic 
Questionnaire (DAPP-BQ) found three distinct personality types in patients 
with NES: (a) a personality type resembling borderline disorder (higher in all 
four higher-order dimensions [emotional dysregulation, dissocial behavior, 
inhibitedness, compulsivity]; 51%), (b) an overly controlled personality 
(increased compulsivity with lower lower-order dimensions such as anxiety, 
self-harm, narcissism, and conduct problems; 44%), and (c) a personality 
resembling avoidant personality disorder (increased emotional dysregulation, 
inhibitidness, and compulsivity; 5%). Cluster analysis using Revised NEO 
Personality Inventory (NEO-PI-R) scores (Cragar, Berry, Schmitt, & 
Fakhoury, 2005) yielded a different three clusters; (a) very high neuroticism, 
low extraversion, low openness, high agreeableness, low conscientiousness, 
(b) average in all domains, and (c) very high neuroticism, average 
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extraversion, low openness, low agreeableness, and average 
conscientiousness. When members of these clusters were examined for 
accompanying pathology on the MMPI-2, the following personality 
descriptions for these clusters were suggested: (a) "depressed neurotics" (high 
on the depression scale), (b) "somatic defenders" (significant somatic 
"conversion V" profile ), and (c) "activated neurotics" (anxiety and not 
depression). Cragar stated that differences in the results of this and Reuber's 
study may be due to the use of different measures.  
 Evidence also suggests that psychopathology differs between people 
with NES only and mixed NES/ES. One study found that dissociative 
disorders and PTSD were more common in pure NES, whereas affective and 
personality disorders were common in both groups (D'Alessio, Giagante, 
Oddo, & Silva, 2006). Another study found that somatoform disorders aside 
from NES are more common in the NES-only population, whereas personality 
disorders are more common among the mixed group (Kuyk, Swinkels, & 
Spinhoven, 2003).  
 Although this review does not attempt to explain the reasons between 
these differences in personality and psychopathology among people with NES 
and ES, it does note that such differences are acknowledged across studies. 
Importantly, the presence of psychological differences signals the utility of 
psychological assessment techniques to help differentiate among people with 
different diagnoses.  
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Differential Diagnosis of Non-epileptic Seizures and Epileptic Seizures 
Diagnosis through physiology. The overlap of symptoms can confuse the 
diagnosis of NES and ES. In one EMU, there was a mean delay of 7.2 years 
from the time of initial NES symptoms and subsequent diagnosis (Reuber, 
Fernández, Helmstaedter, Qurishi, & Elger, 2002). The misdiagnosis of NES 
as ES can have devastating effects on a person's life and health. With a 
diagnosis of ES often comes anti-convulsant medication, with 83% of 
misdiagnosed patients seen in one EMU receiving anti-convulsant 
medications during the course of misdiagnosis (Smith, Defalla, & Chadwick, 
1999). Anti-convulsants can have a host of side effects, including cognitive 
deficits (Goldberg & Burdick, 2001), neurotoxic effects, gingival hypertrophy, 
and gynaecomastia (Smith et al., 1999). Additionally, a misdiagnosis of ES 
may lead to negative psychosocial outcomes, such as loss of driving abilities 
(in one study, 12/14 people had their driving interrupted, with five 
temporarily losing their licenses [Smith et al., 1999]). With loss of driving, or 
with the stigma of ES, can come interruptions in work or demotion. As such, 
it is vital that NES be properly diagnosed as early as possible and before 
these negative effects occur.  
 Routine EEG (r-EEG) is one method that has been used to help with 
the classification of epilepsy. It is generally performed on an outpatient basis 
and involves the gathering of interictal brain activity (Cragar, Berry, 
Fakhoury, Cibula, & Schmitt, 2002). Epileptiform discharges, even in the 
absence of seizure activity, is an indication of ES. Strengths of the r-EEG 
include the relative ease and low expense; however, if a person does not have 
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a seizure event while being monitored, EEG cannot be used as a 
discriminating tool (Cascino, 2002). The (possibly rare) co-occurrence of NES 
and ES may cause a person with mixed NES/ES to be improperly diagnosed 
by the presence or absence of epileptiform activity, missing the opportunity to 
medicate true ES or behaviorally treat NES. Additionally, overinterpretation 
of normal EEG phenomena or non-specific features can lead to a misdiagnosis 
of epilepsy (Cascino, 2002; Eirís‐Puñal et al., 2001; Smith et al., 1999).  
VEEG is considered the "gold standard" of epilepsy and NES 
diagnosis. Lack of epileptiform brain activity during a seizure indicates that 
there is at least an NES component of a person's syndrome, whereas unusual 
electrical activity indicates that a person is having an epileptic seizure. 
VEEG may take place over a number of days, and as such, is more likely to 
capture multiple events; however, even VEEG can be inconclusive if a person 
has no seizure activity during the stay. Certain types of seizures, such as 
frontal lobe seizures, may not show a seizure-like pattern on the EEG 
(Cascino, 2002). In addition, VEEG may not be available in all locations, and 
can be a costly venture in both time and money, costing up to $15,000 
(Wagner, Wymer, Topping, & Pritchard, 2005). As such, though VEEG is an 
immensely important tool in the diagnosis of seizures, additional information 
is usually needed in making a differential diagnosis.   
 Patients with NES often show seizure activity in a manner consistent 
with their beliefs about seizures look like, but that are inconsistent with the 
way seizures physically play out. Observation can therefore be a powerful tool 
in diagnosis. A summary of differences in seizure activity (Reuber & Elger, 
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2003) notes common elements in NES that are rare or very rare in ES, 
including gradual onset, side-to-side head shaking, undulating motor activity, 
asynchronous limb movements, closed eyelids, eyelids that resist opening, 
and lack of cyanosis. An additional symptom that has been considered useful 
in NES and ES differentiation is rhythmic pelvic thrusting, which had been 
suggested as evidence of a history of childhood sexual abuse in NES. But 
although this does occasionally occur in NES, it is also an occasional 
occurrence in frontal lobe epilepsy, though rarely in temporal lobe epilepsy 
(Geyer, Payne, & Drury, 2000). In people with both NES and ES, clinical 
features of their seizures generally differ depending on what type of seizure 
they are having; ES resemble common ES, whereas NES resemble the NES of 
others (Devinsky, 1996). 
Diagnosis through psychological assessment. Another tool that can be 
used in differential diagnosis is the personality inventory. In addition to 
giving physicians valuable information into personality and possible 
psychological dysfunction, knowing how different groups answer such 
questions can aid in making a diagnosis. One of the most commonly used 
tests in a hospital setting is the Personality Assessment Inventory (PAI; 
Morey, 1991). Although this is less studied than other personality 
inventories, such as the MMPI-2, it has been shown to have great promise in 
differential diagnosis (Locke, 2011). The PAI is a 344-item test that 
comprises 22 scales: 4 validity scales, 11 clinical scales, 5 treatment 
consideration scales, and 2 interpersonal scales. Scales were developed 
theoretically based on DSM-IV-TR criteria for Axis I and some Axis II 
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disorders (American Psychiatric Association, 2000), as well as variables that 
assess openness to treatment, alcohol and drug abuse, and interpersonal 
scales. T scores were developed with a community sample of 1000 
individuals.  
 Wagner et al. (2005) was the first to study the use of the PAI in the 
EMU. Using VEEG as a final arbiter for diagnosis, differences were found in 
the SOM-C (Conversion subscale of the PAI Somatization [SOM] scale) 
between people with NES such that people with NES scored significantly 
higher (T score of 71.8 vs. 68.3). As research had found that SOM-C is greatly 
increased in people with conversion disorders and the Health Concerns scale 
is generally increased in people with serious health problems, he additionally 
created an "NES indicator" of SOM-C minus Health Complaints, with the 
hypothesis that a positive result would be an indicator of NES, and a 
negative result would be an indicator of ES. A positive NES indicator yielded 
a 84% sensitivity and a 73% specificity; however, when replicated with a 
larger sample (Thompson, Hantke, Phatak, & Chaytor, 2010), the NES 
indicator was not found to have greater accuracy than the full SOM scale, 
either of SOM's subscales SOM-C and SOM-S (Somatization subscale), or 
DEP-P (Physiological Subscale of the PAI Depression scale). Additionally, in 
Thompson's sample, the mean score on the Health Concerns scale was the 
same with both groups. A further study by Locke et al. (2011) which 
compared those scales of the PAI, MMPI-2 and MMPI-2-RF that had shown 
the most potential for their ability to discriminate ES and NES in an EMU 
sample found that SOM-C at ≥70 was a better discriminator of NES than 
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Wagner's NES indicator subscale, the SOM scale, or the MMPI-2RF scale 
RC1 (Somatic Complaints).  
 Perhaps the most used and best researched personality test is the 
MMPI (Hathaway & McKinley, 1940;  Locke et al., 2011) and its more recent 
versions, the MMPI-2 (Butcher et al., 2001) and the MMPI-2-RF (Ben-Porath 
& Tellegen, 2008). The MMPI was originally developed as a diagnostic 
classification tool, but it became clear that specific diagnostic utility as 
planned, i.e., using single high scores on individual scales such as 
hypochondriasis, depression, and schizophrenia for diagnosis, was poor (for 
names of relevant MMPI-2 and MMPI-2-RF scales and their abbreviations, 
please see Tables 1 and 2); however, it provided useful information for 
psychiatric characteristics through code types and patterns (such as a high 
Hs/Hy or 1-3 code as a predictor of a psychosomatic disorder; McKinley & 
Hathaway, 1944), which gained more interest than individual scales. The 
MMPI was revised in 1989 as the MMPI-2, with new norms, removal of 
offensive, outdated, and irrelevant questions, and creation of new scales, 
including the validity scales VRIN, TRIN, and Fb. In 1995, Fp, S, and the 
PSY-5 scales were added. Review articles (Cragar, Schmitt, Berry, Cibula, 
Dearth, & Fakhoury, 2003; Locke et al., 2010) indicate that people with NES 
tend to have elevations on the MMPI-2 scales 1 and 3, and to a lesser extent, 
2 and 8. These same reviews found that elevations on scales 1 and 3 are good 
differentiators of ES and NES, with lesser differentiation found in scales 2 
and 4, and nonsignificant differences in scale 8. Since then, decision rules 
have been created to best distinguish NES from ES. Three such sets of 
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decision rules are given in Table 3. Wilkus' decision rules for discriminating 
NES from ES using the MMPI (Wilkus, Dodrill, & Thompson, 1984) were 
generally based around the "conversion V" phenomena, whereby elevated Hs 
and Hy scores, which are higher than a lesser-elevated D, are related to 
conversion disorders (Gough, 1946). These decision rules, when applied to ES 
and NES groups, result in a sensitivity of 61-80% and specificity of 40-88% 
(review article; Cragar, Schmitt, Berry, Cibula, Dearth, & Fakhoury, 2003). 
These rules were later modified by Cragar for the MMPI-2 (Cragar, Schmitt, 
Berry, Cibula, Dearth, & Fakhoury, 2003; See Table 3). Sensitivities for the 
modified rules ranged from 58-74%, whereas specificities ranged from 70-
74%. A similar set of decision rules was created by Derry and McLachlan 
(1996) which also capitalizes on the relative elevations of scales 1 and 3 
among people with NES (see Table 3). The original paper, which included 
mixed ES/NES, reported sensitivities of .92 and specificities of .94 using rules 
created after collecting data to maximize classification accuracy in that 
particular group. Using the same decision rules, another study found a 
sensitivity of .71 and specificity of .67 (Warner, Wilkus, Vossler, Wyler, & 
Abson-Kraemer, 1996). 
 A shift in the MMPI-2 occurred in 2003 with the addition of the 
Restructured Clinical (RC) scales as potential replacements of the Clinical 
Scales, designed to decrease the common variance and intercorrelations 
among the Clinical Scales. Variance due to demoralization (high negative 
activation and low positive activation) was removed from all scales to reduce 
correlations between the scales, and was made into its own scale, 
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Demoralization. Scales 5 and 0 (Masculinity-Femininity and Social 
Introversion, respectively) were removed, leaving Demoralization and eight 
scales which generally correspond to the concepts underlying the original 
clinical scales. For example, RC1, Somatic Complaints, measures the same 
general concept as Clinical Scale 1, Hypochondriasis. A major exception is 
RC3, which measures Cynicism rather than Hysteria, and is in fact a reversal 
of the naïveté component of Clinical Scale 3. As 1 and 3 were previously 
highly related, the restructuring removed the intercorrelations such that the 
somatic elements of Clinical Scale 3 are now associated with RC1, which 
independently reflects somatic complaints (in contrast to the MMPI-2's 
"conversion V" of a high 1 and 3; Sellbom, Ben-Porath, McNulty, Arbisi, & 
Graham, 2006). A high score on RC1 and low score on RC3 is meant to 
recreate the somatic complaining and naïveté that was the hallmark of 
Clinical Scale 3.  
 In 2008, the MMPI-2-RF was introduced. It substantially reduced the 
number of items from 567 to 338 to improve efficiency and enhance construct 
validity by removing items with less utility, and utilized many of the same 
methods that were used to develop the RC scales, such as factor analysis 
(Ben-Porath & Tellegen, 2008). It is composed of 50 scales (for a list of MMPI-
2-RF scales used in this review; see Table 1) and is a heterogeneous collection 
of scales from previous MMPI versions as well as scales created by various 
authors and deemed to have optimal utility.  
 A study on the ability of the MMPI-2-RF to distinguish ES from NES 
(Locke et al., 2010) found mean differences in the validity scales Fs and FBS-
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r, clinical scales RC1 and RC3, and somatic scales MLS, GIC, HPC, and NUC 
(Persons with NES scored higher on all these scales except for RC3; for 
descriptions of scales, please see Table 1). FBS-r, RC1, and MLS had the 
largest effect sizes of their respective classifications. At a cut score of T =65, 
RC1 had a sensitivity of 76% and a specificity of 60%, with an overall hit rate 
of 68% (the base rate of NES in the population used in this study, namely, 
people with VEEG-diagnosed NES or ES, was 50.9%). For NUC, at a clinical 
cut score of 65, sensitivity was 91 but specificity was only 27; the hit rate was 
maximized at a cut score of T =85 (sensitivity 53 and specificity of 81; hit rate 
67%). Although there was no optimal clinical cut score determined for FBS-r, 
when FBS-r ≥70, sensitivity was 56 and specificity was 73, with an overall hit 
rate of 64. Locke & Thomas (2011) also developed two scales for the MMPI-2-
RF that measured physical complaints (Psychogenic Nonepileptic Seizures 
Physical Complaints; PNES-pc) and attitudes (Psychogenic Nonepileptic 
Seizures Attitudes; PNES-a). These scales were developed through 
identifying individual questions that differentiate between NES and ES and 
heuristically sorting them into scales, which were then evaluated and refined 
through confirmatory factor analysis. When PNES-pc and PNES-a were both 
≥3, sensitivity and specificity were both 73%.  
 A recent study by Locke et al. (2011) sought to compare the best of the 
decision rules for the PAI (SOM, SOM-C, and NES indicator), MMPI-2 (Derry 
et al. and Wilkus et al. decision rules), and MMPI-2-RF (RC1, PNES 
indicator). In this sample, patients in an EMU were randomly assigned to 
take either the PAI or the MMPI-2, which was additionally scored on the 
   
17 
MMPI-2-RF scales. Of the 78 people who took the PAI, 46 were confirmed by 
VEEG to have ES, whereas 32 had NES; of the 65 that took the MMPI-2, 33 
had ES and 32 had PNES. Between the MMPI-2 and MMPI-2-RF, RC1 ≥65 
had the best discriminating ability with a sensitivity of 97%, specificity of 
50%, and hit rate of 73% (base rate in the population used in this study was 
38%, which included all people with any confirmed diagnosis, including 
mixed NES/ES and other physiological disorders); however, the PAI 
indicators SOM and SOM-C both outperformed the MMPI-2-RF, with SOM 
having a sensitivity of 83, specificity of 77, and hit rate of 79, whereas SOM-C 
had a sensitivity of 72, specificity of 84, and hit rate of 79.  
 As documented above, empirical evidence shows that people with NES 
and ES are different in key ways in both psychopathology and personality. 
Personality tests, including the PAI, MMPI-2, and MMPI-2-RF, can be used 
to predict inclusion in these diagnostic categories. Although VEEG is 
unmatched in its near-certain diagnostic ability, the aforementioned tests are 
inexpensive and do not require costly and rare machinery or a great deal of 
time; as such, they are useful early tools when NES is suspected. 
Importantly, these tests can be used in combination with other relatively 
inexpensive tests, such as r-EEG, to provide incremental classification ability 
(Storzbach, Binder, Salinsky, Campbell, & Mueller, 2000). For people without 
the resources for VEEG, these tests can together provide a picture of what is 
happening with the patient with minimal cost and without travel to a 
specialized hospital. Improving prediction can be an important step toward 
earlier and more accurate diagnosis, potentially preventing patients from 
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taking unnecessary medications, facing negative sociological consequences, 
and losing valuable treatment time. 
Response Bias 
 Response bias, as assessed by what have traditionally been termed 
validity scales, has long been a source of concern for people who create and 
use psychological assessment procedures. Response bias has been described 
as a "consistent tendency to respond inaccurately to a substantive indicator, 
resulting in a systematic error in prediction" (McGrath, Mitchell, Kim, & 
Hough, 2010), where a "substantive indicator" is the psychological 
instrument's scale that is designed to predict a criterion (e.g., the substantive 
scale RC1 may be used to predict a criterion of diagnosis of a somatizing 
disorder). Response bias may be done in such a way to create an unusually 
good impression of psychological functioning; this is known as positive 
impression management (PIM). Conversely, it may reflect functioning that is 
far worse than would be assessed objectively; this is known as negative 
impression management (NIM). Both of these response biases are discussed 
at length in the present review. An additional type of response bias is random 
responding, which may be a result of lack of attention or understanding, or 
other factors. It can be measured by asking paired questions that would be 
expected to be answered either the same way or in opposite ways. An unusual 
number of disagreements on questions where agreements are expected (e.g. 
the VRIN scale on the MMPI; "I have had very peculiar and strange 
experiences" and "I have strange and peculiar thoughts'') or not expected 
(TRIN; "I am a very sociable person" and "I find it hard to make talk when I 
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meet new people") indicate that the test-taker is not responding to the test in 
a meaningful way. Randomly responding to substantive questions invalidates 
substantive indicators and generally, beyond a set cut point of random 
responses, results in the entire protocol being considered invalid and 
discarded. As such, random responding will not be considered in this study, 
and such invalid protocols will not be utilized. 
 Response bias may reflect either unconscious or conscious processes, 
analogous to the psychological concepts of conversion disorder versus 
factitious disorder/malingering. For example, due to unconscious processes, 
persons with poor self-understanding may show an unusually high amount of 
PIM, whereas those with conversion or somatizing disorders may show very 
high NIM. On the other hand, there are many reasons why a person may 
deliberately wish to distort his or her testing results, such as or pre-
employment assessments given in the workplace or child custody evaluations 
(Bagby, Marshall, Bury, Bacchiochi, & Miller, 2006). Similarly, those who 
wish to donate kidneys have been shown to have unusually high PIM scores 
on the PAI (Hurst, Locke, & Osborne, 2010). Overall, it is logical that people 
may wish to give a better impression of functioning in contexts involving 
motivation to get a good job, gain or retain custody of a child, or donate 
organs to friends or family. Research also abounds with contexts where 
deliberate NIM is a concern. In forensic assessment, people may be motivated 
to feign psychological disorders, and in worker's compensation cases or 
litigation, patients may feign somatic and neurological complaints to make a 
better case for a lawsuit (Bagby et al., 2006) 
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  As there are no tests of response bias that can discern a respondent's 
underlying motivation, this (if it exists) must be inferred through the use of 
context. Psychologists must be careful when making conclusions based on 
either clinical or validity scales. People with unusual symptoms will be more 
likely to respond in a way that suggests response bias where it may not exist. 
For example, on the MMPI-2, patients with seizures are likely to score high 
on both the clinical scale Sc and the validity scale F due to legitimately 
bizarre symptoms, such as seeing, hearing, or smelling things that do not 
actually exist. A careful clinician will recognize this context and not assume 
that the patient is faking; however, a patient with a mild traumatic brain 
injury (TBI) obtained in a car crash who never lost consciousness and is suing 
the insurance company should probably be taken with a grain of salt when he 
endorses these same bizarre symptoms.  
Validity scales as discriminators. Many validity (response bias) scales 
have been extensively studied to determine whether they do, in fact, 
discriminate between persons who employ NIM or PIM and those who are 
answering honestly. There are several research designs used in most studies 
of response bias, elucidated by Rogers (2008). The first is simulation 
research, in which participants are asked to feign responses in the way a 
malingerer might do (e.g., pretending they have been in a minor car accident 
and wishing to represent themselves as more injured than they were for 
litigation purposes). These feigned responses are then compared to honest 
responders or a clinical group. This type of testing has high internal validity, 
since it can be carefully standardized and manipulated, but Rogers states 
   
21 
that external validity is weak, since consequences of poor "malingering" are 
generally less grave than in a real situation. He additionally cautions against 
research which compares feigning samples with nonclinical samples, as 
higher scores for clinical reasons may be seen in genuine patients.  
 In known-groups research, studies compare the responding styles of 
independently verified different groups (e.g., malingerers and non-
malingerers). External validity is strong, but internal validity is weak. 
Although known-groups research is in many ways optimal due to high 
external validity, there can be difficulty in independently creating known 
groups, and categorization is rarely 100% accurate, especially when there is 
an intent on the part of the person being classified to be categorized into a 
different group than he/she objectively belongs, as in the case of a malingerer. 
But it should be noted that NES and ES provide an excellent opportunity for 
known-groups research, since group inclusion can be objectively measured 
with VEEG. A lesser-used research strategy is differential prevalence 
designs, in which members of one group are assumed to have a different 
response style than another. For example, in this method, litigants may be 
assumed to be a proxy for malingerers, since there is overlap in these 
populations. Rogers recommends caution when using this research design.  
 In general, studies examine PIM bias indicators (e.g., L and K on the 
MMPI) separately from NIM indicators (e.g. the F family, including FBS-r, 
which contains elements of both PIM and NIM) due to the very different 
populations of interest. NIM is more of a concern in situations where 
respondents have a motivation to appear worse than they are, such as cases 
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of malingering or litigation, whereas PIM is more common when respondents 
are motivated to appear unrealistically virtuous or problem-free, as in pre-
employment assessment or child custody litigation.  
 A 2003 meta-analysis of the utility of NIM indicators on the MMPI-2 
(Rogers, Sewell, Martin, & Vitacco, 2003) indicated that both F and Fp 
(equivalent to Fp-r, see Table 1; the suffix "-r" denotes the scale has been 
restructured for the MMPI-2-RF) discriminated well for feigning, and that Fp 
was especially effective. Other studies have confirmed the ability of F and Fp 
to distinguish between normal participants instructed to malinger and true 
psychiatric patients (Bagby, Nicholson, Bacchiochi, Ryder, & Bury, 2002), 
whereas F and F-back (uncommon responses on the second half of the MMPI-
2) distinguish feigned depression from true depression (Bagby, Nicholson, 
Buis, & Bacchiochi, 2000). In the MMPI-2-RF, FBS-r and Fs were found to 
correlate with failure on symptom validity tests in disability assessment 
settings (Gervais, Lees-Haley, & Ben-Porath, 2007; Wygant et al., 2009). 
More recent meta-analyses of the MMPI-2 found that FBS-r was even more 
effective than the F family in discriminating overreporting in forensic 
contexts (Nelson, Sweet, & Demakis, 2006; Nelson, Hoelzle, Sweet, Arbisi, & 
Demakis, 2010).  
 PIM indices have also found to successfully classify people who 
underreport from those who respond without bias. Studies have found that L-
r and K-r discriminate between those asked to underreport symptoms and 
those filling out the MMPI-2-RF under standard instructions (Sellbom & 
Bagby, 2008). An meta-analysis of 16 studies of PIM on the MMPI-2 found 
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that underreporting responders show differences in validity scale scores by 
around 1 standard deviation on effect sizes (Baer, Wetter, Nichols, Greene, & 
Berry, 1995). This analysis found that the participant and methodological 
variables in the study (e.g., normals vs. patients and uncoached feigning vs. 
coached feigning) affected how much PIM impacted scores on clinical scales. 
In these studies, L-r had effect sizes between -.60 (for coached underreporting 
faking patients vs. normal controls) and 3.07 (normals feigning and normals 
standard), whereas K-r had effect sizes between -.04 and 2.06 (both for 
coached underreporting normals vs. normal controls).  
Biasing clinical scores.  If a response bias reduces the predictive ability of 
a substantive indicator on a criterion, there are two possible ways it can do 
so. If response bias acts as a suppressor, this means that it artificially 
depresses the substantive indicator. If a validity scale score is acting as a 
suppressor, it can be used additively with the substantive indicator to 
enhance the prediction of a criterion. For example, the K correction on the 
MMPI was designed to combat an expected suppressor effect of 
"defensiveness" on the other criteria, with the assumption that a highly 
defensive person will not be honest and forthright about impaired 
psychological functioning. The K correction adds points to other scales 
dependent on how high the K score is. Statistically, the slope of the 
regression of the criterion on the substantive indicator will remain the same 
for all levels of validity scale scores, but the Y intercept will change (McGrath 
et al., 2010; See Figure 1). Thus, in cases of suppression, bias can be 
"corrected for" by adding or removing points on the clinical scales. 
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 Response bias can also act as a moderator by changing the predictive 
ability of the substantive indicators at lower or higher levels. That is, with a 
low or average validity scale score, the substantive indicator may predict a 
criterion with a high degree of accuracy, but as the validity score increases 
(indicating more response bias), the substantive indicator may lose predictive 
validity. VRIN and TRIN are good examples of this effect. With a low VRIN 
(random responding) score, predictive validity may be quite good, but may 
decrease dramatically the more VRIN rises. Likewise, if a person is 
consistently employing PIM or NIM, thereby overreporting or underreporting 
symptoms, the substantive score may not predict the criterion with much 
accuracy (see Figure 2). Statistically, if moderation is in effect, the regression 
slope of the criterion on the substantive indicator will change at different 
levels of validity scale scores such that low response bias will result in a 
higher slope, whereas high response bias may result in an almost horizontal 
slope, indicating no predictive value. In these cases, bias cannot be corrected 
for by adding or removing points, but it is possible that diagnostic utility can 
be improved by recognizing the differential predictive success at different 
levels of response bias. 
 According to McGrath et al. (2010), the best method to test for 
suppression is to demonstrate that a) the substantive indicator is correlated 
with the bias indicator and b) the substantive indicator correlates more 
strongly with the criterion when the bias indicator is partialed out (Cohen, 
Cohen, West & Aiken, 2003). The latter is indicated when the semi-partial 
correlation is larger than the zero-order correlation. An equivalent 
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correlation indicates that there is no suppression effect; a greater correlation 
may indicate that the bias indicator actually adds predictive value (for 
example, if positive impression positively correlates with success in the 
workplace due to a testee's motivation to appear high-functioning). Another 
method is using hierarchical regression analyses, first entering the 
substantive indicator alone, and then together with the bias indicator. If the 
regression coefficient of the substantive indicator increases upon addition of 
the bias indicator, this is indicative of suppression (Millsap, personal 
correspondence). 
 There are at least two ways to measure moderation. One way is to use 
moderated multiple regression, or moderated logistical regression in the case 
of a dichotomized criterion (Cohen, Cohen, West & Aiken, 2003). In this 
procedure, the increase in fit of adding a multiplicative or interaction term to 
a regression determines whether, and how much, moderation exists. A 
second, more clinically useful way of measuring moderation is to examine the 
correlation between the substantive score and the criterion at different levels 
of the response-bias measure (McGrath et al., 2010). If moderation exists, the 
correlations will be lower at higher levels of bias indicator, whereas 
equivalent correlations at different bias indicator levels indicate no 
moderation (if the correlations were higher at higher levels of the bias 
indicator, this would indicate an additive effect of the bias indicator).  
 Although it is generally accepted that bias scores reflect test approach 
style, there has been some debate in the literature as to whether high 
validity scale scores actually do affect the utility of clinical scales. Indeed, 
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McGrath et al.'s (2010) highly contentious recent review article suggests that 
there is not enough evidence to demonstrate that bias indicators 
meaningfully affect the relationship between a substantive indicator and a 
criterion. These authors reviewed a variety of studies involving personality 
assessment, workplace variables, emotional disorders, eligibility for 
disability, and forensic assessment. They stated that there were not enough 
data for drawing conclusions regarding the latter three populations, but for 
the first two, evidence indicated only mild support for the utility of bias 
indicators; however, the majority of the studies reviewed tested only 
moderation or suppression rather than both. Evidence presented below 
suggests that moderation may be seen when there is virtually no overall 
correlation between the substantive scale and the criterion. One may also 
question whether the selected response bias scores, substantive scores, and 
criterion scores relate in such a manner that suppression or moderation 
would even be expected. As an example, one study included in the review 
used the Marlowe Crowne Social Desirability Scale as a bias indicator, 
Perceived Stress Scale as a substantive indicator, and tension physiological 
measures as criteria. Failure to find a moderating or suppression effect in 
this case is likely due to scale choice, and this failure may not generalize to 
bias indicators in general.  
 A major concern regarding the McGrath et al. (2011) review includes 
the overly wide-ranging conclusions reached based on the articles reviewed, a 
concern recently echoed by prominent researchers in the bias indicator field 
(Rohling et al., 2011). The main populations researched in the McGrath et al. 
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review, those being assessed in the workplace, are very different from those 
where criteria involve psychopathology, or where there is strong motivation 
to distort. Motivation to present well on a workplace assessment may reflect 
latent personality characteristics that would actually be assets in the 
workplace, whereas there is little to suggest that impression management in 
psychopathology or forensic studies reflect actual positive attributes. 
Additionally, most of these workplace assessments studied PIM and not NIM, 
which is more commonly a concern in psychopathology. There would seem to 
be little reason to suspect that these results would relate to areas in which 
NIM is frequent, either due to unconscious processes (e.g. somatizing) or 
deliberately (e.g. litigation or forensics). Although McGrath et al.'s suggested 
statistical methodologies regarding bias indicators appear sound (and in fact, 
will be used to inform the statistical choices made in the present study), the 
populations studied and the conclusions reached in their review have limited 
relevance to the present study of NIM and PIM in a medical setting.  
 In contrast to the conclusions of McGrath et al., a recent study by 
Lanyon, Goodstein, and Wershba (unpublished) examined the use of "good 
impression" in making predictions from personality measures and reported 
varied findings. Out of four studies on workplace prediction, two found 
equivalent prediction across good-impression score levels; however, two found 
no overall correlations between the predictor and criterion, but found 
significant correlations at lower levels of good-impression. Three further 
studies involving the assessment of psychopathology found overall stable 
correlations between the predictor/criteria, but at extreme levels of the good-
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impression scale, found significantly smaller correlations. These data indicate 
that studies that merely report correlations may be missing out on valuable 
data, namely a moderating effect.  
 Several studies examined the effect of NIM on scales assessing clinical 
characteristics. One study examining the effect of feigning on clinical scores 
(Burchett & Ben-Porath, 2010) examined how simulated psychopathology 
and somatizing on the MMPI-2-RF affected clinical scales. As expected, 
simulators did show elevations in overreporting scores. Simulators also 
showed elevations on related clinical scales and smaller correlations between 
substantive scales and related criteria than those measured under standard 
instructions. Another study found that students asked to feign schizophrenia 
showed increases in F, and also showed elevated Clinical Scales 6 and 8 when 
compared to true schizophrenics (Bagby et al., 1997). A study on the MMPI-2-
RF examined differences between known malingerers of traumatic brain 
injury (TBI) from non-malingerers and found increases in both FBS-r and the 
MMPI-2-RF somatic scales (Youngjohn, Wershba, Stevenson, Sturgeon, & 
Thomas, 2011). The results of these studies provide evidence that increases 
in NIM response bias scores correspond with increases in clinical scales. 
Unfortunately, in these studies, suppression and moderation effects were not 
tested, so it is unknown whether (or how) these biases affected the 
discriminant utility of the clinical scales. 
 Among these studies of the impact of validity scales on clinical scales, 
there are no data from non-forensic psycho-medical settings. It is possible 
that the findings of studies utilizing forensic or workplace populations do not 
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generalize to a general medical setting, especially in a conversion disorder 
where negative or positive impression are considered to be unconscious 
rather than conscious processes. The present study will begin to fill in this 
gap in the literature.  
Correction for bias. In addition to having response bias scales, some tests 
(e.g. the MMPI-2; the Sixteen Personality Factor Questionnaire, Fourth 
Edition [16PF4; Cattell, Eber, & Tatsuoka, 1970], and the Employment 
Inventory [Paajanen, Hansen, & McLellan, 1993]) also include methods of 
correcting the assumed bias. For example, if a person's answering style 
indicates that he or she is employing PIM, a bias corrector may artificially 
increase some clinical scores under the assumption that, had the respondent 
not been underreporting his or her symptoms, his or her score would have 
been higher. Debate regarding the impact of validity scales on clinical scales 
aside, in general, practitioners tends to favor the use of bias correctors if they 
are offered. A survey of 36 researchers who authored publications regarding 
the use of validity scales in industrial-organizational psychology indicated 
that 56% used tests which had bias correctors and chose to utilize them, 22% 
used tests that had bias correctors but did not utilize them, 14% indicated 
that their tests did not have bias correctors but that they would use them if 
they were available, and only 8% did not have bias correctors and would not 
choose to use them (Goffin & Christiansen, 2003). Perhaps the best known 
bias correction is the K correction on the MMPI and MMPI-2. But currently it 
is not highly regarded, as studies indicate that it does not function 
   
30 
successfully as intended as a suppressor (Barthlow, Graham, Ben-Porath, 
Tellegen, & McNulty, 2002).  
Classification Rates, Sensitivity and Specificity, and Positive Predictive 
Power and Negative Predictive Power 
 Although the aforementioned methods for detecting suppression or 
moderation have been documented in terms of statistical analyses, they do 
not provide immediate practical clinical utility for diagnosticians. One 
method for translating this information for clinicians is finding cut scores on 
clinical scales that best differentiate between members of a target group and 
people who are not members. At any given cut score, accuracy of diagnosis 
can be expressed by determining classification rates, or the percentage of 
people accurately diagnosed by the test. Additional information is provided 
by determining sensitivity and specificity. Sensitivity is the likelihood that a 
member of the target group will be correctly identified, and specificity is the 
likelihood that a person that is not a member of the target group will be 
correctly identified. There is a direct tradeoff between sensitivity and 
specificity: increasing the ability to recognize target group members by 
casting a wider net will cause more nontarget members to be incorrectly 
included in target group membership, and vice versa. Positive Predictive 
Power (PPP) is the proportion of people positively diagnosed by the test in 
question that actually have the condition, whereas Negative Predictive Power 
(NPP) is the proportion of people negatively diagnosed that are actually 
absent of the condition. 
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Bias Indicators of Interest 
Positive Impression Management. The MMPI scales L and K (L-r and K-r 
in the MMPI-2-RF) are both indicators of PIM. These scales measure claims 
of unrealistically good functioning and a general denial of psychopathology. 
Specifically, L-r measures "uncommon virtues", or denial of minor 
shortcomings and faults that most people would admit to (e.g., "At times I 
feel like swearing"), and is composed of 14 items. The MMPI-2-RF Manual 
recommends that a T-score ≥80 is unlikely even for those from very 
traditional backgrounds, and that any absence of clinical elevations in such 
persons is not interpretable. K-r is built of 14 items and measures 
psychological defensiveness, and is referred to as "adjustment validity", or 
how well adjusted a person presents himself/herself (e.g., a "false" scoring of 
"I find it hard to make talk when I meet new people.") The Manual stresses 
that people who truly are well adjusted may also score highly on the K-r 
scale, and that extra-test information should be utilized when determining 
whether the K-r score may be an indication of PIM. But a T-score of ≥70 is 
stated to be uncommon even in very well-adjusted people, and underreporting 
should be strongly suspected such that a lack of clinical elevations is not 
meaningful .  
 Negative Impression Management. The MMPI-2-RF scales F-r and Fs 
are both indicators of NIM. Rather than general psychological adjustment, 
these scales measure an unusually high level of pathology. F-r ("infrequent 
responses") is composed of 32 items and is associated with a broad range of 
psychological, cognitive, and somatic complaints (e.g. "Evil spirits possess me 
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at times"; "I get anxious and upset when I have to make a short trip away 
from home.") Even if a person has many complaints in one category, it is 
unlikely that a person would legitimately have complaints among all those 
categories, so that a high F-r is a reasonable indicator that a person is 
overreporting symptoms of pathology. A T-score of ≥79 is said to be an 
indication of possible overreporting of psychological dysfunction, whereas a T-
score of ≥120 is highly questionable at best. At this level, malingering is 
strongly suspected, and clinical scales are not interpretable. The Fs scale is 
composed of 16 items and measures somatic complaints that are infrequent 
even among verified patients with physical ailments (e.g., "There seems to be 
a lump in my throat much of the time.") Like F-r, these items cover a wide 
variety of complaints such that a person with true somatic complaints would 
be unlikely to endorse enough items to greatly increase Fs. At a T-score of 
≥81, exaggeration is suspected, though it may be possible for those with 
medical complaints. A T-score of ≥100 is very uncommon even for those with 
genuine medical conditions, and scores of the somatic scales should be 
interpreted with caution. 
 The Symptom Validity-revised (FBS-r) scale. FBS-r is an example of 
both PIM and NIM, as it involves presenting as both virtuous and impaired. 
It was created specifically to measure malingering in personal injury 
litigation, and is described by its author as indicative of goal-directed 
behavior, whereby the patient is motivated: 
(1) to appear honest, (2) to appear psychologically normal 
except for the influence of the alleged cause of injury, (3) to 
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avoid admitting pre-existing psychopathology, (4) where pre-
existing complaints are known or suspected to have been 
disclosed to the examining clinician or likely to be disclosed to 
judge or jury, to attempt to minimize those complaints, (5) to 
hide pre-injury behavior which is antisocial or illegal or to 
minimize this if it appears that the behavior will be discovered 
independently, (6) to present an extent of injury or disability 
within perceived limits of plausibility [these limits vary 
widely], (7) and related ends. (Lees-Haley, English, & Glenn, 
1991) 
It was developed "rationally on a content basis" by its author using the 
original MMPI responses and observations of known malingerers. As the 
scale was quite specific in its goals to identify malingerers, it was originally 
called the Fake Bad Scale. It has rightly been pointed out that, by calling it 
this, it implies motivation for all who score highly and is a prejudicial term; it 
has since been renamed Symptom Validity. Meta-analyses indicate that FBS 
is the best MMPI-2 validity scale at differentiating between forensic 
overreporting groups and comparison groups (Nelson et al., 2006). Though it 
was not intended for use other than malingering, it differentiates well 
between other populations, such as ES and NES. This may relate to the 
common characteristics of malingerers and conversion disorders on 
psychological testing; e.g., the MMPI-2 "conversion V" and the MMPI-2-RF 
elevations in RC1 and the somatic scales (Youngjohn et al., 2011), although it 
is again cautioned that the present study is not attempting to explain the 
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psychological characteristics that define persons with NES. There is a 
considerable overlap between the FBS and the MMPI-2 clinical scales 
associated with conversion; i.e., Hy (32.6%) and Hs (30.2%; Nelson et al., 
2006). The FBS-r is composed of 30 items. According to the Manual, at T >80, 
overreporting of symptoms should be suspected. T ≥100 is very rare even 
among those with true somatic ailments, and the somatic and cognitive scales 
should be interpreted with extreme caution. 
Present Study 
 The present study examined the potential role of bias indicators to 
affect the ability of substantive indicators to discriminate between ES and 
NES, either through moderation or suppression. It took two different 
approaches to this question: one purely psychometric, and the other more 
practical. The former method utilized statistical approaches to find the 
presence or absence of moderation or suppression. Finding either of these 
would lend support to studies indicating that bias indicators do impact 
outcomes by affecting other, substantive indicators, while refuting critical 
articles such as McGrath et al. (2010). The second, clinical method assessed 
whether the ability of substantive scores to diagnose ES or NES changed at 
different levels of bias, and did so by examining overall classification rates, as 
well as how sensitivity/specificity and PPP/NPP changed at these different 
optimal classification rates. It was possible to have statistical significance 
without any real clinically significant changes in predictive ability of 
substantive scales. It was also possible that overall optimal classification 
rates would remain the same; i.e. the optimal cut score may have been 
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similar across levels of bias, but the degree to which these cut scores at 
different levels of bias overdiagnosed ES while underdiagnosing NES and 
vice versa may have changed. For example, the same cut score at different 
levels of bias could have had similar classification rates, but PPP could have 
increased and NPP decreased at higher bias, which would be important 
information for a clinician who is more concerned with catching all patients 
with ES (even if more people are incorrectly diagnosed with ES rather than 
NES), or vice versa. These results were specific to this ES/NES population, 
but the conceptual usefulness may generalize to other psychomedical 
populations   
If moderation was found, this study would then determine the range of 
bias indicator scales within which useful discrimination can be made. In the 
case of either moderation or suppression, this study would identify the best 
substantive scales for correctly discriminating patients with NES from ES, as 
well as optimal cut scores on those scales for maximum discrimination, at 
different levels of bias indicators. It would also examine sensitivity/specificity 
and PPP/NPP at different levels of bias. 
As previously stated, the present study builds on the previous work of 
Locke et al. (2010). The choices of substantive scales and bias indicators in 
the present study were based on a review of research and on an empirical, 
rather than theoretical, basis. Although there is certainly room to offer 
possible conceptual reasons for psychometric differences that have previously 
been found between patients with ES and NES (e.g., RC1 measures 
somatizing, which is directly related to NES as a disorder), this study took a 
   
36 
decidedly practical approach to an important practical problem by examining 
the scales that have been found to best differentiate between ES and NES.  
 This study examined the effect of NIM indicators F-r and Fs, and the 
underreporting indicators L-r and K-r, and FBS-r (which contains elements of 
both NIM and PIM) on the clinical scales RC1 and NUC for the purposes of 
discriminating between patients with NES and ES. F-r, Fs, and FBS-r were 
chosen to test NIM because in the present sample, they are significantly 
elevated in patients with NES (as is Fs for patients with ES; Locke et al., 
2010), making these scales of interest in this population. L-r and K-r were not 
elevated in this study, but were chosen to test the how PIM indicators might 
bias clinical indicators. NUC and RC1 were selected for this study because 
they showed the greatest clinical utility in discrimination in this sample.  
Hypotheses: General Formulation 
 It was hypothesized that bias indicators would work in either a 
moderating or suppressing fashion to affect the ability of substantive 
indicators (i.e. RC1 and NUC) to discriminate between ES and NES. For 
either moderation or suppression, use of bias indicators will be able to 
improve diagnosis by adjusting the optimal cut score and diagnostic 
sensitivity and specificity of clinical scales based on response bias scores used 
by clinicians. The presence of moderation would indicate that the differential 
diagnostic utility of substantive scales (i.e. RC1 and NUC) changes as bias 
increases or decreases. The presence of suppression would indicate that the 
optimal cut score on substantive scales changes at different levels of bias, but 
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diagnostic utility at optimal scores would remain similar across different 
levels of bias. 
Negative Impression Management. The indices of negative impression 
management assess biased responses to questions about physical or cognitive 
symptomatology, including the type associated with NES. It was predicted 
that as patients responded in a more biased manner, higher cut scores on 
substantive scales (i.e. RC1 and NUC) would be needed to attain optimal 
differentiation between ES and NES.  
Additionally, if moderation was seen, it was predicted that as patients 
responded in a more biased manner, the differentiating diagnostic utility of 
substantive scales would decrease, such that sensitivity and specificity at 
different cut scores on substantive scales would change at different levels of 
F-r and Fs. In this situation, NIM indices would begin to affect clinical scales 
substantially as these scales approached T scores which the MMPI-2-RF 
Manual suggests indicate possible malingering, i.e. F-r =80 and Fs =81. 
When there was no indication that there is a biased response style at work, 
validity indicators would not substantially affect clinical scales. 
Positive Impression Management. It was predicted that indices of 
positive impression management would also affect clinical scales. 
Underreporting indices such as L-r and K-r do not directly measure 
symptoms, but rather an approach to answering questions in a defensive or 
honest style of responding. Since this response style is less directly related to 
NES symptoms, it was predicted to have less impact on differential diagnosis 
than NIM and FBS-r. The K-r scale, which was found to be significantly 
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higher in the NES population than the ES population in Locke et al.'s sample 
(although this level still did not rise to clinical significance), would affect 
sensitivity and specificity at different cut scores more than L-r, which did not 
discriminate between ES and NES in this sample.  
If moderation was seen, these scales would affect clinical scales at 
both high and low levels. At high scores, it was predicted that discriminating 
ability of clinical scales would be attenuated due to a lack of openness on 
answering questions. A very low level of PIM can be a result of unusual 
honesty and openness or can be a result of endorsing an unusual amount of 
dysfunction (and therefore appearing unusually open). As a result, no 
hypotheses are made as to whether low levels of K-r and L-r would increase 
or impair predictive utility of clinical scales. 
 The Symptom Validity-revised (FBS-r) Scale. FBS-r, as a bias 
indicator, is not historically used for any diagnostic discrimination, including 
medical diagnostic discrimination. Rather, it is used as an indicator of 
whether substantive scales, such as RC1, can be trusted to usefully 
discriminate in cases of personal injury litigation malingering. However, in 
this sample and others, FBS/FBS-r itself discriminated between NES and ES 
such that persons with NES scored significantly higher (Barr, Larson, Alpert, 
& Devinski, 2005; Locke et al., 2010; Nelson, Parsons, Grote, Smith, & 
Sisung, 2006). This may be due to the item content in FBS, which, as 
previously stated, overlaps with the somatizing MMPI-2 scales Hy and Hs. 
Therefore, it was predicted that as FBS-r scores increased, higher cut scores 
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on substantive scales would be needed to attain optimal differentiation 
between ES and NES.  
In the case of moderation, as FBS-r increases, it was predicted that 
substantive scales would be increasingly biased and less able to discriminate. 
It would begin to affect clinical scales substantially as FBS-r approaches T 
scores which the MMPI-2-RF Manual suggests indicate possible malingering, 
i.e. FBS-r =81. As it is itself a predictor of NES or ES, if moderation is seen, 
at a certain FBS-r score (to be determined), the FBS-r score itself would be 
the best predictor of inclusion into the NES or ES group.  
Specific Hypotheses  
In summary, given the potential for response bias to affect a clinical score, 
the hypotheses were as follows: 
Negative Impression Management. 
1a) Indicators of NIM (i.e. F-r and Fs) will moderate or 
suppress substantive scales (optimal predictors RC1 and 
NUC). 
1b) In the case of moderation, at higher levels of NIM, 
diagnostic utility will be attenuated. In the case of 
suppression, diagnostic utility at optimal cut scores will 
be similar across levels of bias. 
1c) For either moderation or suppression, the optimal cut score 
for discrimination between NES and ES will increase at 
higher levels of NIM.   
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Positive Impression Management. 
2a) Indicators of PIM (i.e. K-r and L-r) will moderate or 
suppress substantive scales. 
2b) In the case of moderation, there will be a moderating effect 
of the substantive scales on the criteria at both high and 
low levels. At high levels of PIM, diagnostic utility of 
clinical scales will be attenuated. No hypotheses are 
made as to the directionality of how low scores on 
underreporting indices will affect clinical scales. In the 
case of suppression, diagnostic utility at optimal cut 
scores will be similar across levels of bias. 
2c) For either moderation or suppression, the optimal cut score 
for discrimination between NES and ES will decrease as 
PIM increases. In the case of suppression, diagnostic 
utility at optimal cut scores will be similar across levels 
of bias. 
2d) PIM will affect clinical scales less than NIM. 
The Symptom Validity-revised (FBS-r) Scale. 
3a) FBS-r will either moderate or suppress substantive scales. 
3b) If moderation is seen, at higher levels of FBS-r, diagnostic 
utility will be attenuated. In the case of suppression, 
diagnostic utility at optimal cut scores will be similar 
across levels of FBS-r. 
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3c) The optimal cut score for discrimination between NES and 
ES will increase as FBS-r increases.  
3d) If moderation is seen, at a certain FBS-r score, the 
predictive utility of FBS-r alone will be higher than that 
of the substantive scales RC1 and NUC. 
Method 
Procedure 
 All participants were inpatients in the EMU at the Mayo Clinic 
Hospital in Phoenix, Arizona between April 2001 and April 2009. A total of 
664 patients were admitted (14 of these were second admissions during the 
same time period and were not included in the final results), and all were 
given the MMPI-2 as part of a standard neuropsychological evaluation 
(recoded later into the MMPI-2-RF). Patients were weaned off antiepileptic 
medications and were monitored with VEEG, where epileptiform discharges 
were recorded simultaneously with video monitoring. Diagnosis was 
determined from VEEG discharge summary and was made according to the 
following criteria: 
 Epilepsy only: Typical events occurred with epileptiform discharge, or, 
in the absence of the occurrence of typical events, the description of a typical 
event was concerning for epilepsy and interictal epileptiform discharges were 
noted.  
 NES only: Typical events occurred without epileptiform discharge. 
There was no interictal epileptiform discharge, and no physiological reason 
for the seizure-like events. 
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 Both Epilepsy and NES: Typical events occurred multiple times, some 
with and some without epileptiform discharges, or typical events occurred 
without epileptiform discharges but interictal epileptiform activity was noted.  
 Indeterminate: No typical events nor interictal discharges were 
recorded, resulting in no diagnosis. 
Participants 
 Of the 664 patients, 221 were diagnosed with epilepsy, 219 were 
diagnosed with NES, 24 were diagnosed with both ES and NES, 166 were 
indeterminate, and 34 patients were diagnosed with other physiological 
disorders such as sleep, autonomic nervous system, or vascular disorders. 
Patients other than pure ES or NES were excluded from inclusion in the 
study. After excluding the re-admissions among the NES and ES patients, 
the study was left with 215 ES and 214 NES patients.  
 Record review gathered the following information: age, sex, 
handedness, ethnicity, length of disorder, years of education, seizure 
frequency, current number of anti-epileptic medications being taken, current 
psychiatric medications, psychiatric history (broadly defined to include a 
diagnosis of a psychiatric issue, self-report of mood or psychiatric problems, 
history of individual, family, or marital counseling, evaluation from a 
psychiatrist, medication for a psychiatric issue, or inpatient psychiatric 
hospitalization) and substance abuse history (see Table 4 for descriptives). 
Basic Statistical Analyses  
 Moderation. To determine whether response bias indicators act as 
moderators, two methods were used. The first method utilized moderated 
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logistical regression. Moderation, in this instance, occurred if the odds of a 
correct diagnosis increased when an interaction term (response bias score 
multiplied by clinical scale score) was included in the model. This method is 
statistically powerful since it allows all independent variables to remain 
continuous. A second method of measuring moderation examined the 
correlation between clinical scale scores and diagnosis at different levels, or 
cut slices, of the response-bias measure. Although less powerful, this method 
might pick up on moderation that only occurs at extremes, or very high/very 
low levels of validity scale scores.  
 Suppression. To determine whether response bias indicators act on 
substantive indicators as suppressors, binary logistic regression was used 
with and without the bias indicator as a covariate, whereby X1 =a 
substantive indicator, X2 =a bias indicator, and Y =VEEG-confirmed 
diagnosis (e.g., X1 =RC1, X2 =FBS-r, and Y=NES or ES). If the bias indicator 
is significant, this indicates that it has an additive effect to the substantive 
indicator for diagnosis. In addition, if the standardized regression coefficient 
of the substantive indicator is greater when the bias indicator is added, the 
bias indicator acts as a suppressor, since by being partialed out in the model, 
the relationship between the substantive indicator and the criterion becomes 
stronger. Each of the two substantive indicators and the five bias indicators 
were tested. 
Analyses with Clinical Utility: Classification Rates, Sensitivity and 
Specificity, and Positive Predictive Power and Negative Predictive Power. In 
addition to testing moderation and suppression, an overall correct 
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classification rate for different cut scores at different levels of bias can be 
calculated. Unlike statistical tests of moderation and suppression, this can 
offer immediate clinical utility for those using the MMPI-2-RF to aid in 
diagnosis of ES or NES. It can provide information about the likelihood that, 
at or above a particular cut score, a person will be accurately classified into a 
target or nontarget group (in this case, the target group is ES and the 
nontarget group is NES). Classification rates are determined by choosing a 
cut-score on the substantive indicator and calculating the number of people 
at or above that score that are correctly identified as members of the target 
group or non-target group divided by the total sample. 
Sensitivity and specificity were also calculated at relevant cut scores of 
the substantive indicators for different levels of bias indicators. Like 
classification rates, sensitivity and specificity offer clinical utility for 
diagnosticians using the MMPI-2-RF. Sensitivity and specificity provide 
additional information to clinicians about the ability of a particular test score 
to accurately sort a person, and whether inaccuracies are due to 
inappropriately sorting people into the target group or the non-target group. 
Sensitivity is determined by choosing a cut-score on the substantive indicator 
and calculating the number of people at or above that score that are correctly 
identified as members of the target group (true positives) divided by the total 
number of people in the target group (true positives plus false negatives). 
Specificity is similarly determined by calculating the number of negatives 
accurately sorted into the nontarget group (true negatives) divided by the 
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total number of members of the nontarget group (true negatives plus false 
positives).  
Another method of garnering useful information from the data is to look 
at positive predictive power (PPP) and negative predictive power (NPP). PPP 
is the proportion of people positively diagnosed by the test in question that 
actually have the condition, whereas NPP is the proportion of people 
negatively diagnosed that are actually absent of the condition. PPP and NPP 
are thus useful for deciding how likely it is that a person above a certain cut 
score is accurately or inaccurately diagnosed. PPP calculation is true 
positives / (true positives + false positives), whereas NPP is true negatives / 
(true negatives + false negatives). PPP and NPV has an additional useful 
aspect in that it can be calculated at different base rates (BR) than the 
sample if sensitivity and specificity are known; if doing this, PPP =(BR x 
sensitivity) / (BR x sensitivity) + [(1-BR) x (1-specificity)], and NPP =1-BR) x 
specificity / [(1-BR x specificity) + [BR x (1-sensitivity)]. 
Classification rates, sensitivity, specificity, PPP, and NPP were calculated 
at a number of substantive cut scores (e.g., RC1 score of T ≥50, ≥55, ≥60, 
≥65...) separately for people at different levels of bias indicators (e.g., F-r 
scores of T =0-49, 55-64...). In addition to providing information about the 
likelihood of a particular test score to accurately sort into diagnostic groups, 
the optimal cut scores of substantive indicators for accurate classification of 
diagnosis can be determined for people expressing different levels of bias 
indicators. To ensure adequate power, minimum sample size of each slice was 
determined according to methods espoused by Buderer (1996) using a 
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confidence interval of 95%, a confidence interval width of ± 10 for sensitivity 
and specificity scores (e.g., if sensitivity was found to be 80, it is 95% certain 
that the actual sensitivity falls between 70 and 90), and an expected 
minimum sensitivity or specificity of 65%. This yielded a minimum sample 
size per slice of 89. 
Results 
Basic Statistical Analyses 
 Correlations between each of the substantive indicators, bias 
indicators, and the criterion were performed, and are shown in Table 5. Bias 
indicators were minimally related to the criterion (NES vs. ES), with all 
these variables being correlated at ≤0.15, with the exception of FBS-r, which 
was correlated at 0.32. This indicates that, except for FBS-r, bias indicators 
are not acting as independent predictors of the criterion. 
Moderation. The presence of moderation was tested through two 
methods. 
 Binary logistic regression. Moderated logistic regression yielded no 
significant moderating effects of bias indicators for either RC1 or NUC. 
Power to detect effects, calculated using G*Power, was calculated at 0.97 
(Hsieh, Block, & Larsen, 1998; Millsap, personal communication, 2012; 
Buchner et al., 2009). Results are shown in Table 6.  
  Correlations between substantive indicators and diagnosis. To test for 
moderation via correlation of clinical scale scores and diagnosis at different 
slices of the response-bias measure, bias indicators were divided into three or 
four different slices. Number of slices, as well as cut scores at slices, was 
   
47 
determined by adherence to the Manual guidelines of meaningful cut scores 
(when possible), and otherwise, attempting to create the maximum number of 
groups while maintaining adequate sample size in each group. Because T 
scores were not evenly distributed, this led to some bias indicators being split 
into three groups and others into four groups. This has precedence in the 
Manual; likely due to the same issues, the Manual-suggested cut scores of 
clinical importance are not congruent between bias indicators, nor are the 
ranges of scores within each clinically important slice within in a single bias 
indicator the same. 
 Correlations of substantive indicators and the criterion were performed 
at different levels of bias. These correlations were then compared to each 
other using a Fisher r-to-z comparison, using an internet application (Lowry, 
R., 2001-2012). Power analyses calculated using G*Power indicated that the 
sample size was insufficient to detect any differences between groups 
(Buchner et al., 2009); maximum power attained in comparing correlations 
was only .25. In fact, for a power of 0.8, 3146 participants would be required. 
Nonetheless, analyses were run as an exercise. Results, shown in Table 7, 
indicate that none of the correlations were significantly different from each 
other for either RC1 or NUC. No moderating effect of bias indicators was 
demonstrated, but it is again warned that these analyses were insufficiently 
powered.  
Suppression analyses for RC1. Suppression was tested through 
hierarchical binary logistic regression, whereby the substantive variable and 
each bias variable were individually entered in a sequence to test how much 
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the bias variable added to the model. Each analysis was composed of RC1 and 
one only bias indicator. All suppression analyses are shown in Table 8. 
 RC1 alone. RC1 was first entered alone in binary logistic regression 
model (B =0.069, s.e =0.009, p=.000).  
 Addition of bias indicators. F-r was added into the original model and 
was significant (B= -0.031, s.e. =0.009, p=.000). The regression coefficient for 
RC1 increased (B =0.094, s.e.=0.012, p=.000). 
Fs was added into the original model and was significant (B =-0.024, 
s.e. 0.008, p=.000). The regression coefficient for RC1 increased (B =0.091, s.e. 
=0.012, p=.002). 
L-r was added into the original model and was significant (B =0.031, 
s.e. 0.011, p=.000). The regression coefficient for RC1 increased (B=0.076, s.e. 
=0.009, p=.000). 
K-r was added into the original model and was significant (B =0.068, 
s.e. = 0.012, p=.000). The regression coefficient for RC1 increased (0.089, s.e. 
=0.010, p=.000). 
FBS-r was added into original the model and was not significant (B 
=0.000, s.e. =0.012, p =.970). The regression coefficient for RC1 stayed the 
same (B=0.069, s.e., 0.012, p=.000). 
The finding that the addition of bias indicators F-r, Fs, L-r, and K-r 
increased RC1’s beta coefficient demonstrated that each of these bias 
indicators suppressed RC1’s ability to discriminate between ES and NES ; 
however, the addition of FBS-r did not increase or decrease RC1’s beta 
coefficient, indicating that it did not suppress RC1.  
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Suppression analyses for NUC. Suppression was tested in the same 
way as was done for RC1. Results of suppression analyses are shown in Table 
8. 
 NUC alone. NUC was first entered alone in binary logistic regression 
model (B=0.065, s.e.= 0.008, p=.000).  
Addition of bias indicators. F-r was added into the original model and 
was significant (B =-.023, s.e. =.010, p =.004). The regression coefficient for 
NUC increased (B =.081, s.e. =.010, p =.000). 
Fs was added into the original model and was significant (B =-.017, 
s.e. .007, p =.023). The regression coefficient for NUC increased (B =.078, s.e. 
=.011, p=.000). 
L-r was added into the original model and was significant (B =.031, 
s.e.=.011, p =.005). The regression coefficient for NUC increased (B=.071, 
s.e.=0.009 p=.000). 
K-r was added into the original model and was significant (B =.048, 
s.e.=.012, p =.000). The regression coefficient for NUC increased (B =0.74, s.e 
=.009, p=.000). 
FBS-r was added into the original model and was significant (B =.024, 
s.e. =.009, p =.009). The regression coefficient for NUC decreased (B=.052, s.e. 
=0.010, p=.000). 
The finding that the addition of bias indicators F-r, Fs, L-r, and K-r to 
NUC increased NUC’s beta coefficient indicates that these bias variables 
suppressed NUC’s ability to discriminate between ES and NES. Addition of 
FBS-r decreased rather than increased NUC’s beta coefficient. Since FBS-r 
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was also independently significant, this indicates that FBS-r can be used 
additively with NUC to improve prediction of the criterion, but it does not do 
so through suppressing NUC.  
Analyses with Clinical Utility 
Classification rates. After assessing for moderation or suppression, 
analyses for clinical utility were run. To determine classification rates and 
sensitivity/specificity, bias indicators were each split into either three or four 
groups of similar size (minimum n of 89) depending on the MMPI-2-RF 
Manual suggested cut scores and distributions of T scores within each 
indicator. Based on these criteria, F-r’s slices were T =0-54, 55-64, 65-78, and 
≥79; F-s’s slices were T =0-59, 60-79, and ≥80; L-r’s slices were T=0-49, 50-59, 
and ≥60; K-r’s slices were T =0-44, 45-54, and ≥55; and FBS-r’s slices were T 
=0-54, 55-64, 65-79, and ≥80.  
RC1 and NUC were then sliced at scores of T ≥50, ≥55, ≥60, ≥65... ≥95. 
For each level of bias (e.g. for F-r, T =0-54), all persons above each 
substantive cut score, (e.g. for RC1, T ≥50), were predicted to be diagnosed 
with NES. These predictions were then compared to the number of persons 
that, at or above that cut score, were actually diagnosed with NES via the 
gold standard of VEEG. Those that were predicted to have NES and were 
actually diagnosed with NES were considered to be true positives; those that 
were predicted to have NES but were diagnosed ES were false positives; 
those predicted to have ES but were diagnosed with NES were false 
negatives, and those both predicted to have and diagnosed with ES were 
considered true negatives. Sensitivity, specificity, and classification rates 
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were determined using the number of people in each category as described 
previously. Ten such sets of analyses were conducted, one for each 
predictor/bias-indicator combination. Table 9 shows one of these analyses, for 
RC1 and F-r.  
As this study is concerned with the manner in which NIM, PIM, and 
FBS-r may affect substantive indicators, and as trends for these bias 
indicators were similar for RC1 and NUC, classification trends will be 
reported by bias indicator and not substantive indicator.  
Negative Impression Management: F-r and Fs. For both RC1 and 
NUC, optimal cut scores as determined by overall classification rate tended 
to increase as NIM increased. For RC1, at F-r <55, optimal classification rate 
of 69% occurred at T ≥60 and 65, whereas at F-r ≥79, optimal classification 
rate of 67.5% occurred at T =75. NUC showed some variability, with a higher 
cut score for F-r <55 (optimal classification rate of 67.0% occurred at T =85), 
than for mid-ranges of F-r, which otherwise followed the trend of requiring 
higher cut scores at higher levels of bias for optimal classification rates (i.e., 
T ≥75 for F-r =56-64 and T ≥85 for T =65-78). For F-r ≥79, optimal 
classification rate of 72.2% occurred at T =90.  
This trend also occurred for F-s. For RC1, at F-s <60, optimal 
classification rate of 69.8% occurred at T ≥60, whereas for F-s ≥80, optimal 
classification rate of 68.1% occurred at T ≥70 and T ≥75. For NUC, at F-s <60, 
optimal classification rate of 64.7% occurred at T ≥80, whereas for F-s ≥80, 
optimal classification rate of 73.2% occurred at T ≥85.  
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Positive Impression Management: L-r and K-r. For L-r and K-r, the 
opposite tendency was seen; at higher levels of bias, cut scores for optimal 
classification rate occurred at lower levels of bias. For RC1, at L-r <50, 
optimal classification rate of 66% occurred at T ≥75, whereas at L-r ≥60, 
optimal classification rate of 75.8% occurred at T =60. For NUC, at for L-r 
<50, optimal classification rate of 74.1% occurred at T ≥85, whereas for L-r 
≥60, optimal classification rate of 70.2% occurred at T ≥70. 
Similarly, for RC1, at K-r <45, optimal classification rate of 71.0% 
occurred at T ≥75, whereas at K-r ≥55, optimal classification rate of 76.0% 
occurred at T ≥60. For NUC, at K-r <45, optimal classification rate of 72.5% 
occurred at T ≥90, whereas for K-r ≥55, optimal classification rate of 71.9% 
occurred at T ≥70. 
 FBS-r. Optimal classification rates for different levels of FBS-r were 
not calculated for RC1 because no suppression or moderation was found. For 
NUC, the trend for FBS-r was similar to that of L-r and K-r; at FBS-r <55, 
optimal classification rate of 75.8% occurred at T ≥70, whereas at FBS ≥80, 
optimal classification rate of 69.4% occurred at below at or below T ≥55. At 
those T-scores, that optimal classification rate has a sensitivity of 100% and a 
specificity of 0%; that is, the best overall classification rate occurs when it is 
predicted that a person with an FBS-r score of T ≥80 is properly diagnosed 
with NES, regardless of the NUC score.  
 Sensitivity and specificity. It is notable that optimal classification 
alone does not give a full picture of differences seen at different levels of bias. 
As shown in Tables 11 and 12, sensitivity and specificity changed at different 
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levels of bias, even when classification rates were similar; for example, at F-r 
<55, similar classification rates of 69% were seen for RC1 ≥60 and RC1 ≥65; 
however, sensitivity dropped from 57% for RC1 ≥60 at to only 38% for RC1 
≥65, whereas specificity rose for those scores from 76% to 87%. Sensitivity 
tended to decrease as substantive scores increased, whereas specificity 
increased. In general, for F-r and Fs, specificity tended to be higher for low 
levels of bias and specificity tended to be higher for high levels of bias; the 
opposite tendency is seen for L-r and K-r. Interestingly, FBS-r tends to follow 
the same trend as F-r and Fs (that is, higher specificity at low levels of bias 
and higher sensitivity at higher levels of bias).  
 Positive Predictive Power and Negative Predictive Power. Similarly to 
sensitivity and specificity, PPP and NPP in this sample were not adequately 
represented by classification rates alone, as shown in Tables 13 and 14. In 
general, NPP tended to decrease as substantive scales increased, whereas 
PPP increased as substantive scores decreased. This was true regardless of 
level of bias indicator or whether the bias indicator represented NIM or PIM. 
Discussion 
 The aim of this study was to examine the propensity of bias indicator 
scores to affect the ability of substantive indicators to distinguish between ES 
and NES, a conversion disorder that mimics of the physical manifestations of 
seizures without any underlying neurological activity. This study had two 
major goals: to psychometrically assess whether bias variables act in a 
moderating or suppressing manner in this situation and to determine the 
most accurate cut scores for clinicians working with ES and NES. Results 
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indicated that, in these data, bias indicators do indeed suppress substantive 
indicators, but moderation was not found. In response to this suppression, 
tables were created to improve accuracy of prediction of ES or NES based on 
substantive scales. 
This present study has some methodological limitations regarding the 
use of overall classification rate to determine the best cut score. This method 
was chosen because it is intuitive for clinicians, as well as being the statistic 
chosen by Locke et al. (2010) in the study which the present study builds on. 
One alternative to classification rates is ROC curves, graphical plots 
illustrating sensitivity and specificity at all possible points on the variables. 
The advantage of ROC curves is that the T-scores can remain continuous, 
rather than looking at particular, previously determined cut scores; however, 
ROC curves, compared to overall classification rates, are less intuitive for 
clinician use. Additionally, the use of previously-determined cut scores was 
modeled after similar usage in the Manual, as well as by other researchers in 
the field.  
Another alternative to classification rates for optimal cut score 
determination is examining the odds ratio, or the ratio of the odds of an event 
occurring in one group compared to the odds of it occurring in other group 
(e.g., being diagnosed with NES in a group with vEEG-diagnosed NES or 
vEEG-diagnosed ES). This method might be statistically preferable, since 
logistic regression, the statistic used in the present study, uses the odds ratio 
in its modeling. It was not used in this study for similar reasons as the ROC 
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curve; namely, it is not particularly clinician-friendly, and this study strives 
to be of optimal use clinically.  
Another limitation of the study is the nature of the sample used. Well 
over 90% of the sample was Caucasian. Although this is a result of the true 
sample of inpatients at this particular location, it may not reflect 
psychosocial differences seen differentially among ethnic groups. Future 
studies should endeavor to ensure adequate representation among different 
ethnic groups.  
 Suppression but not moderation was found with these participants. 
Moderation, in which the relationship between the substantive variable and 
the outcome is different at different levels of bias, is a possibility when the 
two bias groups are fundamentally different, such as males and females (in 
some contexts) or people with entirely different medical conditions. But those 
participants with higher or lower levels of NIM or PIM are not fundamentally 
different from those with average symptom reporting, especially in the 
context of a disorder that has exaggerated symptoms as its hallmark. All 
persons exist on a continuum of response bias, either through unconscious 
reasons or accurate endorsement of problems (in the case of NIM), or good 
coping strategies (in the case of PIM). It therefore follows that suppression 
rather than moderation would be found in this sample. 
 These results add information to the bias indicator literature, and 
further dispute the findings of McGrath et al. (2010), which stated that bias 
indicators neither moderate nor suppress substantive indicators. Their 
conclusions were drawn in regard to several areas in which bias indicators 
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are used, including personality assessment and workplace variables. They 
further reported that dearth of data in other contexts, such as emotional 
disorders, forensic testing, and disability eligibility, indicate that utility of 
bias indicators is currently untested. The data from the present study 
indicate that in the context of psycho-medical testing, there are indeed 
suppression effects of MMPI-2-RF bias indicators on substantive indicators 
for ES and NES discrimination. The present author is unaware of other 
studies in this unique and very important context. These data therefore 
support the position of Rohling et al. (2011), who state that there is evidence 
in clinical situations (especially in clinical neuropsychology) to support the 
utility of bias indicators in enhancing prediction. At the least, these findings 
support the need for further studies on how bias can affect substantive scales.  
 Since suppression was found in the present study, additional clinically 
relevant statistics were run. Suppression was illustrated by changes in 
optimal cut scores for best overall classification; for negative impression 
management scales (i.e. F-r and Fs), optimal cut scores increased with higher 
bias indicator scores, whereas for positive impression management scales (i.e. 
L-r and K-r), optimal cut scores decreased with higher bias indicator scores. 
Although suppression was not seen for FBS-r, it was found that as FBS-r 
scores increased, the optimal cut score on NUC decreased. These changes in 
optimal cut scores indicate that it may be in a patient’s best interest for a 
clinician, when determining the probability of a correct diagnosis, to choose 
take into account the patient’s level of bias.  
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 For the present participants, these changes in optimal cut scores are 
statistically significant, but it may be questioned whether they are clinically 
significant. Locke et al.’s 2010 study, using the same data, indicated that 
RC1 was the best predictor of NES or ES at a cut score of 65, with 68% 
accuracy. In the present study, the greatest increase in accuracy by looking at 
classification at different levels of bias was found at different levels of K-r; 
accuracy increased from 68% at a blanket RC1 T-score of 60 or 65 to 73% 
when calculated at optimal cut scores, an overall increase of 5% accuracy 
(this greatest increase in accuracy is consistent with the suppression 
analyses, in which K-r had the largest beta of the bias indicators)
 However, the level of increase is not static across levels of bias. The 
optimal cut score for moderate K-r was indeed 65, but for the lowest level of 
K-r, a cut score of 65 only accurately predicts 62% of people, compared to 71% 
at RC1 = 75; and for high K-r, a cut score of 65 only accurately predicts 70% 
of people, compared to 76% at RC1 = 60. For moderate levels of K-r, the 
optimal cut score was RC1 = 65, so for people with moderate levels of K-r, 
there is no difference from the overall optimal cut score. In the sample of 131 
people with low levels of K-r, an additional 12 people would be accurately 
diagnosed by using an optimal cut score as compared to a blanket score for all 
people (93 compared to 81); for the 146 people with high levels of K-r, 9 extra 
people are accurately diagnosed at a different cut score (111 vs. 102). It can 
be argued that these differences in overall hit rates are both statistically and 
clinically significant for people with high or low levels of K.  
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 It is not clear why using K-r as a suppressor made the greatest 
difference of all the bias indicators. In an attempt to understand these 
results, the individual items were examined (see Table 15 for analyses). It 
was found that the K-r scale is composed of 10 “self” items (e.g. “I certainly 
feel useless at times”) and four “other” items (e.g. “It takes a lot of argument 
to convince most people of the truth”). Individual analyses were then 
conducted of these 14 items. Five of the “self” items and all four “other” items 
were found to individually suppress RC1’s diagnostic ability for ES/NES. Of 
the five “self” items, patients tended to respond in the opposite direction to 
good adjustment on three of those items, indicating that they felt useless and 
that they had many troubles piling on, and they frequently worried. The 
other two “self” items were about more social aspects of adjustment (i.e.” I do 
not find it hard to make talk when I meet new people” and “I get mad easily 
easily and then get over it again soon”), and these were coded in the direction 
of greater adjustment. Of the four “other” items, NES patients coded other 
people as especially well-adjusted on all items. ES patients coded other as 
well-adjusted on two items (though not to the degree of the NES people) and 
not well-adjusted on two others. In summary, the K-r items that acted as 
suppressors were items in which patients (especially NES patients) indicate 
that other people are very well adjusted, but they themselves are not. 
 These analyses suggest several possible reasons why K-r worked best 
as a suppressor. The “other” items that were endorsed as false by patients, 
and also worked to discriminate between people with NES and ES, are all 
also coded on RC3, or cynicism. As stated in the Manual, a high RC1 and low 
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RC3 score is suspicious for a conversion disorder. It may be that people with 
lower levels of the RC3 items combined with higher “self” items may be 
underreporting somatization symptoms (as measured by RC1) to attempt to 
“fit in” with a world that they see as extraordinarily well-adjusted. 
Additionally, K-r is a measure of attitude, and questions about what others 
think or do can be seen as subtle measures of how the test-takers view 
themselves. That is, test-takers who state that others are well adjusted may 
be unconsciously suggesting that they themselves have those thoughts or 
tendencies. The more obvious “self” items that were coded as true endorse 
problems or anxieties that may directly relate to problems that they 
experience because of their illness, and is thus not inconsistent with a 
conceptualization of a generally emotionally healthy world.  
 Another important finding concerns the differences in 
sensitivity/specificity as the cut score changed. For the lowest levels of K-r, at 
the overall RC1 best cut score of T= 65, sensitivity was .87 and specificity was 
.43; at the optimal cut score for high K of RC1 T = 75, sensitivity was .67 and 
specificity was .74. Sensitivity decreased appreciably, whereas specificity 
increased appreciably. For clinicians choosing the cut score they wish to use, 
it may be important for them to choose not based on overall correct 
classification, but rather based on a careful examination of whether they are 
more interested in correctly classifying those with the disease (NES) or 
correctly classifying those with ES. If clinicians decide they would rather 
ensure that all patients with NES are flagged by the MMPI-2-RF (a relatively 
inexpensive and easy test to give as a first screener) and sent for further 
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testing at an EMU, they may choose the cut score of T= 65, even though the 
hit rate is lower due to the larger number of people inaccurately sorted as 
NES. On the other hand, if clinicians felt it was more important to avoid 
giving further expensive tests, such as an EMU stay, to people who do not 
need them, they may choose the higher cut score of T = 75, even though 
people with NES will be missed. Each clinician may wish to look at the trade-
off between sensitivity and specificity at each cut score and choose the one 
that makes most sense for their patient base.  
 Likewise, if a clinician has a patient with a particular RC1 score, he or 
she can look at PPP/NPP to determine the likelihood that the patient was, in 
fact, accurately sorted as NES or ES. A patient who scored at RC1 T = 65 and 
had a low level of K-r bias would only be correctly identified as NES 53% of 
the time, or close to chance (PPP), but a person who scored lower than T = 65 
would be correctly identified as ES 83% of the time (NPP); however, for a 
person with a high level of K-r bias, PPP is .78 and NPP is only .63. In other 
words, clinicians can be surer about whether they can confidently diagnose as 
ES or NES if they take bias into account.  
The present study lends support to the practice of using bias indicators as 
suppressors and raises many interesting questions for future studies, while 
also providing tables for clinical use in discriminating between NES and ES 
for similar situations. It is hoped that future studies will investigate the use 
of suppressors in other psycho-medical settings, where bias scales may not be 
traditionally utilized beyond excluding persons that have bias scores above a 
particular cut score. Additionally, other tests such as the PAI may also 
   
61 
increase discrimination through accounting for bias suppression in NES/ES 
studies as well as other contexts. Although this study was able to determine 
the best suppressor for ES/NES discrimination in the present sample, it was 
not able to predict beforehand which scale would work best as a suppressor, 
as there is a dearth of literature as to what makes scales act as suppressors. 
This lack of research provides a further avenue of future studies. Pinpointing 
what makes a good suppressor will be a strong way to improve discrimination 
by narrowing the bias indicators to be tested, as well as lending itself to a 
greater understanding of what psychological forces can blur the usefulness of 
substantive scales.  
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Table 1 
Scales from MMPI-2-RF 
Scale Scale Name 
Validity Scales  
? Cannot Say 
VRIN-r Variable Response Inconsistency 
TRIN-r True Response Inconsistency 
F-r Infrequent Responses 
Fp-r Infrequent Psychopathology Responses 
Fs Infrequent Somatic Responses 
FBS-r Symptom Validity 
L-r Uncommon Virtues 
K-r Adjustment Validity 
  
Restructured Clinical Scales  
RCd Demoralization 
RC1 Somatic Complaints 
RC2 Low Positive Emotions 
RC3 Cynicism 
RC4 Antisocial Behavior 
RC6 Ideas of Persecution 
RC7 Dysfunctional Negative Emotion 
RC8 Aberrant Experiences 
RC9 Hypomanic Activation 
  
Somatic/Cognitive Scales  
MLS Malaise 
GIC Gastrointestinal Complaints 
HPC Head Pain Complaints 
NUC Neurological Complaints 
COG Cognitive Complaints 
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Table 2 
Clinical Scales from MMPI-2 
No. Abbreviation Scale Name 
1 Hs Hypochondriasis 
2 D Depression 
3 Hy Hysteria 
4 Pd Psychopathic Deviance 
5 Mf Masculinity-Femininity 
6 Pa Paranoia 
7 Pt Psychasthenia 
8 Sc Schizophrenia 
9 Ma Hypomania 
0 Si Social Introversion 
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Table 3 
Decision Rules for Epileptic and Non-epileptic Seizures 
Source Decision Rule 
1 2 3 
Wilkus et al. 
(1984) 
NES indicated if any of the following occur 
Scale 1 or 3 is T >70 
and is one of the two 
highest scales 
discounting Scales 5 
or 0 
Scale 1 or 3 is T >80 Scales 1 and 3 
are T >59 and 
10 points 
higher than 
Scale 2 
Derry & 
McLachlan 
(1994) 
NES indicated if all of the following occur 
Scale 1 or 3 is T >70 
and is one of the two 
highest scales 
discounting Scales 5 
or 0 
Scale 1 or 3 is T >80 Scales 1 and 3 
are T >59 and 
10 points 
higher than 
Scale 2 
Modified 
Wilkus et al. 
(1984) 
NES indicated if any of the following occur 
Scale 1 or 3 is T >65 
and is one of the two 
highest scales 
discounting Scales 5 
or 0 
Scale 1 or 3 is T >80 Scales 1 and 3 
are T >59 and 
10 points 
higher than 
Scale 2 
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Table 4 
Demographics and History by Diagnostic Group 
Variable ES NES t/χ2 
M SD n M SD n 
Age 42.18 15.29 214 43.77 13.87 215   -1.12 
Gender (female) .64 — 214 .82 — 215 16.50** 
Ethnicity (White) .92 — 214 .94 — 215 .59 
Handedness (right) .86 — 214 .88 — 215 .24 
Education 13.85 2.32 214 14.01 2.32 215 -.72 
Frequency of seizures 1.92 1.92 214 1.44 1.44 215   3.63** 
Current psychotropic 
medicines 
.27 — 214 .53 — 215 30.12** 
Presence of psychiatric 
history 
.53 — 214 .81 — 215 34.97** 
Presence of substance use 
history 
.16 — 214 .19 — 215 .37 
WRAT-4 Reading 99.93 9.32 194 99.48 11.67 182 .41 
WAIS-III Full Scale IQ 99.73 11.91 191 100.60 13.84 158     -.63 
Note. ES = Epileptic seizures; NES = Non-epileptic seizures. **p < .01. 
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Table 5 
Correlations between Phenotypic Variables 
  1 2 3 4 5 6 7 8 
1 ES/NESa —        
2 RC1  .41** —       
3 NUC  .40**   .81** —      
4 F-r  .11*   .60**   .55** —     
5 Fs  .15**   .64**   .59**   .60** —    
6 L-r  .03  -.21**  -.22** -.16** -.15** —   
7 K-r  .12*  -.30**  -.18** -.55** -.35**   .29** —  
8 FBS-r  .32**   .79**   .57**   .49**   .53**  -.12*  -.18** — 
Note. aCriterion variable. ES = Epileptic seizures; NES = Non-epileptic 
seizures. *p < .05, **p < .01. 
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Table 6 
Moderation Tests of the Interaction between Bias and Substantive Indicators 
  RC1   NUC 
Bias 
indicator 
Scales entered B SE Bias 
indicator 
Scales entered B SE 
F-r RC1  .095** .012 F-r NUC  .081** .011 
 F-r -.029 .009  F-r -.024* .008 
 RC1 x F-r -.001 .000  NUC x F-r  .000 .001 
F-s RC1  .092** .012 F-s NUC  .081** .011 
 Fs -.023** .008  Fs -.020** .008 
 RC1 x Fs  .000 .000  NUC x Fs  .001 .000 
L-r RC1  .077** .010 L-r NUC  .071** .009 
 L-r  .033** .011  L-r  .031** .011 
 RC1 x L-r  .001 .001  NUC x L-r  .000 .001 
K-r RC1  .091** .010 K-r NUC  .075** .009 
 K-r  .069** .013  K-r  .049** .012 
 RC1 x K-r  .001 .001  NUC x K-r  .001 .001 
FBS-r RC1  .072** .014 FBS-r NUC  .052** .010 
 FBS-r  .001 .012  FBS-r  .024** .009 
 RC1 x FBS-r -.001 .001  NUC x FBS-r  .000 .001 
Note. *p < .05, **p < .01. 
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Table 7 
Correlations between Substantive Indicators and Diagnostic Outcome 
(Epileptic Seizures or Non-epileptic Seizures) at Different Levels of Bias 
Indicatorsa  
  RC1 NUC n 
F-r <55 .39* .32* 100 
F-r =55-64 .42* .36* 108 
F-r =65-78 .49* .50* 113 
Fr ≥79 
 
.35* .37* 108 
Fs <60 .32* .37* 116 
Fs =60-79 .43* .41* 156 
Fs ≥80 
 
.39* .41* 157 
Fbs-r <55 .28* .18* 99 
Fbs-r =55-64 .40* .41* 108 
Fbs-r =65-79 .26* .29* 124 
Fbs-r ≥80 
 
.26* .25* 98 
L-r <50 .38* .43* 158 
L-r =50-59 .41* .42* 147 
L-r ≥60 
 
.48* .42* 124 
K-r <45 .43* .37* 131 
K-r =45-54 .44* .41* 152 
K-r ≥55 .50* .50* 146 
Note. a No correlations within each bias indicator were statistically different 
from each other. *p < .05. 
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Table 8 
Regression Coefficients with the Addition of Bias Indicator for Each Pair of 
Substantive and Bias Indicators 
  RC1   NUC 
Bias 
indicator 
Scales entered B SE Bias 
indicator 
Scales entered B SE 
No bias 
indicator 
RC1  .069** .009 No bias 
indicator 
NUC  .065** .008 
F-r RC1  .094** .012 F-r NUC  .081** .011 
 F-r -.031** .009  F-r -.017** .008 
F-s RC1  .091** .012 F-s NUC  .078** .011 
 Fs -.024** .008  Fs -.017** .007 
L-r RC1  .076** .010 L-r NUC  .071** .009 
 L-r  .031** .011  L-r  .031** .011 
K-r RC1  .089** .010 K-r NUC  .075** .009 
 K-r  .068** .012  K-r  .048** .012 
FBS-r RC1  .069** .013 FBS-r NUC  .052** .010 
 FBS-r  .000 .012  FBS-r  .024** .009 
Note. **p < .01. 
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Table 9 
True Positives (TP), False Positives (FP), False Negatives (FN),  True 
Negatives (TR), Sensitivity (sens), Specificity (spec), and 
Classification Rates (CR) for F-r and RC1  
  RC1 T-score 
    ≥50  ≥55 ≥60  ≥65  ≥70 ≥75  ≥80 ≥85 ≥90 
F-r <55 TP 34 27 21 14 7 2 1 1 0 
 
FP 42 26 15 8 4 0 0 0 0 
 
FN 3 10 16 23 30 35 36 36 37 
 
TN 21 37 48 55 59 63 63 63 63 
 
Sens .92 .73 .57 .38 .19 .05 .03 .03 .00 
 
Spec .33 .59 .76 .87 .94 1.00 1.00 1.00 1.00 
 
CR .55 .64 .69 .69 .66 .65 .64 .64 .63 
           F-r =55-64 TP 54 51 49 38 27 10 6 3 1 
 
FP 48 41 25 16 9 3 1 0 0 
 
FN 1 4 6 17 28 45 49 52 54 
 
TN 5 12 28 37 44 50 52 53 53 
 
Sens .98 .93 .89 .69 .49 .18 .11 .05 .02 
 
Spec .09 .23 .53 .07 .83 .94 .98 1.00 1.00 
 
CR .55 .58 .71 .69 .66 .56 .54 .52 .50 
           F-r =65-78 TP 61 61 61 60 53 35 24 13 7 
 
FP 51 48 41 30 20 10 7 3 2 
 
FN 0 0 0 1 8 26 37 48 54 
 
TN 1 4 11 22 32 42 45 49 50 
 
Sens 1.00 1.00 1.00 .98 .87 .57 .39 .21 .11 
 
Spec .02 .08 .21 .42 .62 .81 .87 .94 .96 
 
CR .55 .58 .64 .73 .75 .68 .61 .55 .50 
           F-r ≥79 TP 62 62 60 55 51 47 40 34 23 
 
FP 45 44 37 34 30 20 17 9 4 
 
FN 0 0 2 7 11 15 22 28 39 
 
TN 1 2 9 12 16 26 29 37 42 
 
Sens 1.00 1.00 .97 .89 .82 .76 .65 .55 .37 
 
Spec .02 .04 .20 .26 .35 .57 .63 .80 .91 
 
CR .58 .59 .64 .62 .62 .68 .64 .66 .60 
Note. CRs in bold are the best classification rates for that bias level. 
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Table 10 
Optimal Cut Scores and Classification Rates (CR) for All Levels of Bias 
a
 
 RC1 cut 
score 
RC1 CR NUC cut 
score 
NUC CR 
F-r <55 60 and 65 .69 85 .67 
F-r =55-64 60 .71 75 .65 
F-r =65-78 70 .75 85 .73 
F-r ≥79 75 .68 90 .72 
     
Fs <60 60 .70 70 .66 
Fs =60-79 65 and 70 .71 80 .67 
Fs ≥80 70 and 75 .68 85 .73 
     
L-r <50 65 and 75 .66 85 .74 
L-r =50-59 70 .70 85 .67 
L-r ≥60 60 .76 70 .70 
     
K-r <45 75 .71 90 .73 
K-r =45-54 65 and 70 .72 80 and 85 .70 
K-r ≥55 60 .76 70 .72 
     
FBS-r <55 — — 85 .76 
FBS-r =55-64 — — 80 .69 
FBS-r =65-79 — — 70 .62 
FBS-r ≥80 — — ≤55 .69 
Note. 
a 
Cut scores and classification rates were not determined for different 
levels of FBS-r for RC1, since no suppression or moderation was found. 
  
Table 11 
Sensitivity (Sens) and Specificity (Spec) for RC1 at All Levels of Bias  
 RC1 T  ≥50 RC1 T  ≥55 RC1 T  ≥60 RC1 T  ≥65 RC1 T  ≥70 RC1 T  ≥75 RC1 T  ≥80 RC1 T  ≥85 RC1 T  ≥90 
 Sens Spec Sens Spec Sens Spec Sens Spec Sens Spec Sens Spec Sens Spec Sens Spec Sens Spec 
F-r <55 .92 .33 .73 .59 .57 .76 .38 .87 .19 .94 .05 1.00 .03 1.00 .03 1.00 .00 1.00 
F-r =55-64 .98 .09 .93 .23 .89 .53 .69 .70 .49 .83 .18 .94 .11 .98 .05 1.00 .02 1.00 
F-r =65-78 1.00 .02 1.00 .08 1.00 .21 .98 .42 .87 .62 .57 .81 .39 .87 .21 .94 .11 .96 
F-r ≥79 1.00 .02 1.00 .04 .97 .20 .89 .26 .82 .35 .76 .57 .65 .63 .55 .80 .37 .91 
   
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
Fs <60 .92 .32 .85 .44 .74 .67 .53 .79 .34 .86 .11 .97 .04 .98 .00 1.00 .00 1.00 
Fs =60-79 1.00 .08 .91 .27 .90 .48 .75 .68 .54 .83 .28 .93 .16 .94 .07 .98 .06 1.00 
Fs ≥80 1.00 .02 1.00 .05 .97 .19 .94 .25 .88 .38 .73 .60 .62 .07 .49 .84 .29 .90 
   
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
L-r  <50 .99 .07 .95 .15 .93 .28 .87 .46 .72 .57 .54 .78 .42 .83 .03 .94 .21 .96 
L-r =50-59 .99 .09 .94 .20 .89 .47 .78 .59 .67 .73 .42 .85 .29 .91 .21 .95 .13 .97 
L-r ≥60 .97 .26 .91 .49 .84 .67 .67 .77 .52 .86 .34 .93 .27 .93 .19 .95 .11 .98 
   
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
K-r <45 1.00 .07 .98 .11 .87 .43 .87 .43 .82 .55 .67 .74 .53 .78 .44 .88 .27 .93 
K-r = 45-54 .97 .09 .95 .20 .90 .42 .85 .59 .71 .73 .45 .86 .33 .89 .23 .96 .15 .99 
K-r ≥55 .98 .25 .89 .50 .84 .66 .65 0.77 .46 .86 .27 .95 .02 1.00 .11 1.00 .05 1.00 
7
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Table 12 
Sensitivity (Sens) and Specificity (Spec) for NUC at All Levels of Bias  
 NUC T  ≥50 NUC T  ≥55 NUC T  ≥60 NUC T  ≥65 NUC T  ≥70 NUC T  ≥75 NUC T  ≥80 NUC T  ≥85 NUC T  ≥90 
 Sens Spec Sens Spec Sens Spec Sens Spec Sens Spec Sens Spec Sens Spec Sens Spec Sens Spec 
F-r <55 1.00 .06 .95 .32 .65 .56 .65 .56 .51 .75 .30 .86 .16 .92 .11 1.00 .00 1.00 
F-r =55-64 1.00 .00 .98 .06 .91 .23 .91 .23 .85 .42 .71 .58 .49 .77 .33 .92 .15 .96 
F-r =65-78 1.00 .00 1.00 .04 .98 .12 .98 .12 .97 .23 .90 .29 .87 .50 .74 .73 .52 .88 
F-r ≥79 1.00 .00 .98 .04 .98 .04 .98 .04 .95 .11 .89 .26 .85 .41 .81 .57 .71 .74 
   
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
Fs <60 1.00 .06 .96 .33 .72 .52 .72 .52 .58 .73 .40 .81 .38 .87 .26 .94 .08 .95 
Fs =60-79 1.00 .00 .99 .06 .94 .23 .94 .23 .91 .38 .79 .52 .59 .73 .44 .85 .26 .95 
Fs ≥80 1.00 .00 .99 .02 .99 .03 .99 .03 .97 .11 .90 .24 .84 .40 .78 .67 .66 .79 
   
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
L-r  <50 1.00 .01 .99 .10 .95 .14 .95 .15 .91 .23 .84 .35 .79 .57 .71 .77 .57 .85 
L-r =50-59 1.00 .01 .99 .09 .92 .25 .92 .25 .88 .43 .72 .60 .64 .68 .54 .80 .38 .92 
L-r ≥60 1.00 .04 .97 .21 .85 .42 .85 .42 .78 .61 .66 .67 .49 .81 .36 .93 .21 .96 
   
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
K-r <45 1.00 .00 .98 .05 .96 .16 .96 .16 .91 .29 .78 .38 .71 .54 .65 .70 .55 .86 
K-r = 45-54 1.00 .03 .96 .12 .88 .22 .88 .22 .85 .36 .78 .53 .72 .69 .56 .85 .44 .89 
K-r ≥55 1.00 .03 1.00 .22 .89 .42 .89 .42 .83 .58 .68 .69 .54 .81 .45 .94 .24 .98 
   
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
FBS-r <55 1.00 .03 .89 .21 .57 .41 .57 .41 .43 .65 .36 .76 .29 .87 .29 .94 .07 .99 
FBS-r =55-64 1.00 .02 1.00 .15 .94 .31 .94 .31 .83 .48 .64 .64 .51 .82 .36 .89 .26 .95 
FBS-r =64-79 1.00 .02 .99 .06 .96 .13 .96 .13 .93 .19 .81 .29 .67 .46 .57 .75 .39 .88 
FBS-r >80 1.00 .00 1.00 .00 .97 .00 .97 .00 .97 .03 .91 .13 .87 .27 .75 .53 .62 .67 
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Table 13 
Positive Predictive Power (PPP) and Negative Predictive Power (NPP) for RC1 for All Variables 
 RC1 T  ≥50 RC1 T  ≥55 RC1 T  ≥60 RC1 T  ≥65 RC1 T  ≥70 RC1 T  ≥75 RC1 T  ≥80 RC1 T  ≥85 RC1 T  ≥90 
 PPP NPP PPP NPP PPP NPP PPP NPP PPP NPP PPP NPP PPP NPP PPP NPP PPP NPP 
F-r <55 .45 .88 .51 .79 .58 .75 .64 .71 .64 .66 1.00 .64 1.00 .64 1.00 .64 — .63 
F-r =55-64 .53 .83 .55 .75 .66 .82 .70 .69 .75 .61 .77 .53 .86 .51 1.00 .50 1.00 .50 
F-r =65-78 .54 1.00 .56 1.00 .60 1.00 .67 .96 .73 .80 .78 .62 .77 .55 .81 .51 .78 .48 
F-r ≥79 .58 1.00 .58 1.00 .62 .82 .62 .63 .63 .59 .70 .63 .70 .57 .79 .57 .85 .52 
   
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
Fs <60 .53 .83 .56 .78 .65 .75 .68 .67 .67 .61 .75 .56 .67 .55 — .54 — .54 
Fs =60-79 .46 1.00 .49 .80 .57 .86 .65 .78 .71 .70 .76 .63 .69 .59 .71 .58 1.00 .58 
Fs ≥80 .60 1.00 .61 1 .64 .80 .65 .73 .68 .69 .73 .60 .75 .55 .82 .52 .82 .46 
   
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
L-r  <50 .50 .86 .51 .75 .55 .82 .60 .79 .61 .69 .69 .64 .70 .61 .82 .59 .84 .57 
L-r =50-59 .51 .88 .53 .79 .62 .81 .64 .73 .71 .70 .73 .60 .75 .57 .79 .55 .82 .54 
L-r ≥60 .61 .88 .68 .82 .75 .78 .78 .67 .81 .60 .85 .55 .82 .52 .81 .50 .86 .52 
   
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
K-r <45 .44 1.00 .44 .89 .53 .83 .53 .83 .57 .81 .65 .76 .63 .69 .73 .68 .75 .64 
K-r = 45-54 .53 .78 .56 .79 .62 .79 .69 .79 .73 .70 .78 .60 .76 .56 .86 .54 .92 .53 
K-r ≥55 .63 .89 .70 .78 .76 .76 .78 .63 .81 .56 .88 .50 1 .49 1.00 .47 1.00 .45 
Note. Dashes indicate that PPP or NPP could not be calculated because of a zero in the denominator. 
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Table 14 
Positive Predictive Power (PPP) and Negative Predictive Power (NPP) for NUC for All Variables 
 NUC T  ≥50 NUC T  ≥55 NUC T  ≥60 NUC T  ≥65 NUC T  ≥70 NUC T  ≥75 NUC T  ≥80 NUC T  ≥85 NUC T  ≥90 
 PPP NPP PPP NPP PPP NPP PPP NPP PPP NPP PPP NPP PPP NPP PPP NPP PPP NPP 
F-r <55 .39 1.00 .45 .91 .46 .73 .46 .73 .54 .72 .55 .68 .55 .65 1.00 .66 — .63 
F-r =55-64 .51 — .52 .75 .55 .71 .55 .71 .60 .73 .64 .66 .69 .59 .82 .57 .80 .52 
F-r =65-78 .54 — .55 1.00 .57 .86 .57 .86 .60 .86 .60 .71 .67 .76 .76 .70 .84 .61 
F-r ≥79 .57 — .58 .67 .58 .67 .58 .67 .59 .63 .62 .63 .66 .68 .71 .68 .79 .65 
   
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
Fs <60 .47 1.00 .55 .91 .56 .69 .56 .69 .65 .68 .64 .61 .71 .63 .78 .60 .57 .55 
Fs =60-79 .44 — .45 .83 .48 .83 .48 .83 .53 .85 .56 .77 .63 .70 .70 .66 .82 .63 
Fs ≥80 .60 — .60 .50 .60 .67 .60 .67 .62 .70 .64 .63 .68 .63 .78 .67 .83 .61 
 
  
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
L-r  <50 .48 1.00 .50 .89 .50 .75 .51 .75 .52 .73 .55 .71 .63 .75 .74 .74 .78 .68 
L-r =50-59 .49 1.00 .51 .88 .54 .76 .54 .76 .59 .78 .63 .69 .66 .66 .72 .65 .82 .61 
L-r ≥60 .55 1.00 .59 .86 .63 .71 .63 .71 .70 .70 .70 .62 .75 .58 .86 .55 .88 .51 
   
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
K-r <45 .42 — .43 .80 .45 .86 .45 .86 .48 .81 .48 .71 .53 .72 .61 .74 .73 .72 
K-r = 45-54 .52 1.00 .54 .75 .54 .64 .54 .64 .58 .69 .64 .70 .71 .70 .80 .65 .81 .60 
K-r ≥55 .57 1.00 .62 1 .66 .75 .66 .75 .72 .73 .74 .63 .79 .58 .90 .57 .95 .50 
   
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
FBS-r <55 .29 1.00 .31 .83 .28 .71 .28 .71 .32 .74 .37 .75 .47 .76 .67 .77 .67 .73 
FBS-r =55-64 .44 1.00 .47 1.00 .51 .86 .51 .86 .55 .78 .58 .70 .69 .68 .71 .64 .80 .62 
FBS-r =64-79 .59 1.00 .59 .75 .61 .70 .61 .70 .61 .67 .61 .52 .63 .50 .76 .56 .82 .51 
FBS-r >80 .69 — .69 — .69 .00 .69 .00 .69 .33 .70 .40 .73 .47 .78 .48 .81 .43 
Note. Dashes indicate that PPP or NPP could not be calculated because of a zero in the denominator. 
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Table 15 
Individual K Items’ Ability to Differentiate between Epileptic Seizures and 
Non-epileptic Seizures 
K item Item description Coded 
“true” 
overall 
Coded 
“true” 
ES 
only 
Coded 
“true” 
NES 
only 
23 At times I feel like smashing things. .28 — — 
72 At times my thoughts have raced ahead 
faster than I could speak them. 
.75d .67 .82 
202 I have never felt better in my life than I do 
now. 
.08c — — 
322 Criticism or scolding hurts me terribly. .47c — — 
338 I frequently worry .43 — — 
     
10a It takes a lot of argument to convince most 
people of the truthb 
.31d .36 .26 
36a I think a great many people exaggerate 
their misfortunes in order to gain the 
sympathy and help of othersb 
.47d .58 .36 
44a I find it hard to make talk with others .35d .40 .30 
89a I certainly feel useless at times .54 — — 
99a Most people will use somewhat unfair 
means to gain profit or an advantage 
rather than to lose itb 
.41d .47 .35 
155a I get mad easily and then get over it soon .36d .41 .31 
171a I think nearly anyone would tell a lie to 
keep out of troubleb 
.47d .55 .40 
187a I have sometimes felt that difficulties were 
piling up so high  that I couldn’t 
overcome them 
.58 — — 
338a I frequently find myself worrying about 
something 
.60 — — 
Note. a Denotes items that suppress RC1’s ability to differentiate ES and 
NES. bDenotes items with an “other” rather than “self” focus. cDenotes 
items coded such that “true” is indicative of defensiveness dDenotes 
differences in % coded true for ES and NES at p < .05. 
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Figure 1. Illustration of suppression. In this example, overresponders 
have a similar regression slope to normal responders, but the same 
substantive scale score consistently predicts a lower criterion score.
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Figure 2. Illustration of moderation. In this example, the substantive 
scale cannot be used to predict the criterion with any degree of 
accuracy for those with high negative impression management. 
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